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MRSA DECOLONIZATION
Executive Summary
Staphylococcal carriage, particularly Methicillin-resistant Staphylococcus aureus
(MRSA), is a risk factor for surgical site infection (SSI). The purpose of this project was to
determine whether adult patients undergoing total hip and total knee arthroplasty could be
successfully decolonized of MRSA beginning on the day of surgery, and if decolonization would
reduce surgical site infection (SSI) rates.
The study employed two theoretical frameworks: Nola Pender’s Health Promotion
Model and Kurt Lewin’s Change Theory. The sample consisted of 50 patients, 10 cases and 40
controls, selected from a convenience sample of 299 patients who underwent total hip or total
knee arthroplasty from May 1, 2012 to May 1, 2013 at a large Midwestern teaching hospital. A
case-control study design was utilized. Data was collected using retrospective chart review.
Characteristics of cases and controls were compared on categorical variables using Chisquare statistics. Fisher Exact tests were used when expected cell frequencies were less than 5.
For continuous variables, independent group t-tests were used for comparisons. Evaluation of
change in infection rates pre to post surgery was done using the Wilcoxon test. The small
sample size precluded meaningful inferential statistical tests related to these variables.
MRSA colonization in the cases was reduced from 100% to 30% (7/10) pre to post
surgery in the case patients. No prediction can be made about reducing SSI related to the limited
sample size. A multisite study is recommended to address this limitation.
This pilot project suggests that screening for existing nasal MRSA and beginning
decolonization on the day of surgery for patients undergoing THA or TKA surgery may
effectively result in temporary decolonization during the perioperative period and may
potentially prevent a MRSA SSI.
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Chapter 1

Background and Significance of the Project
Patients colonized with methicillin-resistant Staphylococcus aureus (MRSA) who are
planning to undergo total hip or total knee arthroplasty may be at greater risk for acquiring a
surgical site infection (SSI). The National Healthcare Safety Network (NHSN) at the Centers for
Disease Control and Prevention (CDC) reports that MRSA has been found to be a pathogen in
SSIs and other complications that can occur during the post-operative period (Hidron et al.,
2008). Surgical site infections result in prolonged hospital stays, readmissions and increased
mortality rates (Anderson & Kaye, 2009; Gupta, Strymish, Abi-Hadar, Williams, & Itani, 2011;
Whitehouse, Friedman, Kirkland, Richardson, & Sexton, 2002). Such adverse health outcomes
unfavorably affect patient safety and impact the rising costs of health care.
Anderson and Kaye (2009), report that S. aureus is the most frequent causative agent of
SSIs. Staphylococcus aureus resistance to antibiotics is growing. Jernigan (2004, p. 458), of the
CDC, stated:
Data from National Nosocomial Infections Surveillance (NNIS) System hospitals
reported between 1992 and 2002 show that among SSIs following CABG,
cholecystectomy, colectomy, and total hip replacement, the overall proportion caused by
S. aureus increased from 16.6% to 30.9%; the proportion of S. aureus infections
attributable to MRSA increased from 9.2% to 49.3% (Centers for Disease Control and
Prevention, National Nosocomial Infection Surveillance [NNIS] System, unpublished
data, May 5, 2004).
The increase in MRSA is a factor impacting quality medical care.
Up to 15 million operations are performed each year in the United States (U.S.) alone
(Anderson & Kaye, 2009). According to the Society for Healthcare Epidemiology in America
(SHEA)/Infectious Diseases Society of America (IDSA) Practice Recommendations, “SSIs occur
in 2%-5% of patients having inpatient surgery in the U.S., and approximately 500,000 SSIs occur
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annually” (Anderson et al., 2008, p.1). SSIs increase morbidity and mortality in surgical
patients. Hospital length of stay can be increased by 7-10 days related to SSIs, and if one has an
SSI the risk of death increases 2-11 times when compared to that of a patient without an SSI
(Anderson et al., 2008). Studies suggest that from an economic perspective, preoperative
screening and decolonization of patients undergoing orthopedic surgery is a simple and costeffective patient safety measure that may reduce the risk of SSI, while saving money for
hospitals and third-party payers (Courville et al., 2012; Lee et al., 2010).
This paper describes a pilot project in a large teaching hospital system in the Midwest.
Currently the nares of all patients in this facility are screened for MRSA on admission, transfer,
discharge and death. Admission swabs are analyzed by polymerase chain reaction (PCR) and
results are available within one hour. Given the availability of admission MRSA screening
results, the Orthopedic surgery group believed preoperative MRSA decolonization might be a
strategy to consider to further decrease their already low SSI rate in total hip arthroplasty (THA)
and total knee arthroplasty (TKA) patients. An infection preventionist, orthopedic surgeon, and
the hospital epidemiologist were interested in adding MRSA decolonization to the perioperative
routine which would change the standard of care for THA and TKA surgeries at this facility by
temporarily decolonizing patients and possibly reduce the risk of a MRSA SSI.
A proposal for a systems change project (SCP) to implement decolonization of patients
undergoing total hip and total knee surgery at the time of surgery was submitted to the health
facility’s Institutional Review Board (IRB) as well as to the St Catherine University IRB, and
was approved. The goal of the project was to implement MRSA decolonization at the time of
surgery in adult patients undergoing total hip or total knee arthroplasty, who were known or
newly screened positive, and to determine what proportion of these patients could be temporarily
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decolonized. It was further hypothesized that temporary decolonization might reduce SSIs when
compared to the standard of care at the facility, which at the time the project was proposed was
no decolonization at all.
Quality improvement could be measured and evaluated by implementing such a project.
Patients colonized with MRSA would receive a more appropriate prophylactic antibiotic and
may be temporarily decolonized during the perioperative and immediate postoperative period,
when the risk of SSI is the greatest. Decolonization of MRSA positive THA/TKA patients could
potentially decrease the risk of SSI for this patient population, and decrease the MRSA burden in
the hospital overall as well. As noted earlier, the orthopedic subspecialty historically has a low
SSI rate for clean surgical procedures such as THAs and TKAs. However, the group indicated
an interest in reducing the SSI rate even further by using an evidence-based approach and
implementing decolonization.
Decolonization of MRSA positive THA/TKA patients as a project implemented over one
year as a proposed innovation would require an interdisciplinary approach. Unit nurses, CRNAs,
orthopedic physicians, lab and pharmacy were involved. Communication with all partners would
be critical, including union involvement related to participation of unit nurses and CRNAs at the
time of project implementation. Initial diffusion would occur as the protocol was implemented
with discussion taking place among the various groups. Diffusion would continue to occur as the
results of the project were evaluated and disseminated.
Project Objectives
The project objective was to determine the short term success of methicillin-resistant
MRSA decolonization at the time of surgery for patients undergoing total hip and total knee
procedures and to determine whether decolonization at the time of surgery is effective in
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reducing the rate of surgical site infection (SSI). The primary endpoint for this project is to
identify the proportion of patients undergoing total hip or total knee arthroplasty successfully
decolonized beginning on the day of surgery. Positive outcomes for this project will simplify
and target the management of surgical patients by reducing the risk of MRSA SSIs. This could
be significant at the local level and beyond.
Systems change and principles of social justice. Access to quality medical care is a
social justice issue. Patients should expect quality care that addresses not only physical aspects
of care but psychological and spiritual aspects as well. The facility is a regional referral center
for orthopedic surgeries. Patients may be referred from other Midwestern states. Many of the
patients scheduled for these procedures are aging individuals, without other health care coverage.
A decolonization procedure would decrease the risk of MRSA SSIs for individuals having
surgeries that require orthopedic implants. This intervention will not change accessibility for
patients. It may minimize the risk of SSI which will improve the quality of care, health
outcomes and contribute to patient satisfaction. It is socially responsible to provide this service
for this group of patients.
Beyond the physical signs and symptoms, acquisition of a MRSA infection can have an
undesirable psychological effect on patients and families as isolation will be required. Isolation
precautions not only sequester the patient, they may reduce the frequency and duration of
encounters between patients and their health care providers (Kirkland, 2009). If healthcare
facilities have a high prevalence of MRSA, a decolonization procedure may decrease the risk of
MRSA SSIs for surgical patients that require orthopedic implants. If successful, decolonization
will improve the quality of care, health outcomes and contribute to patient and family
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satisfaction by reducing the burden of MRSA in a hospital. It is socially responsible to attempt
MRSA preoperative nasal decolonization.
Social justice, racial disparity, and joint replacement surgery. An additional aspect
of TKA surgery related to social justice is that of racial disparity. A Healthy People 2010
objective called for eliminating racial disparities in the rate of total knee replacement among
persons ≥ 65 years (CDC, 2009, p. 133). This disparity was not explained by varying risk for
knee osteoarthritis. The CDC indicated disparate access to health care probably did not explain
the disparity. It was further stated “Several reports have indicated that racial disparity in Total
Knee Replacements (TKR) procedures persists even after adjusting for access to clinical care”
(CDC, 2009, p. 137). Non-white Medicare beneficiaries are more likely to have the procedure at
a hospital that performs fewer TKRs per year and where adverse outcomes are more common
(CDC, 2009).
According to research by Ibrahim, Siminoff, Burant and Kwoh (2002), African-American
patients had more concerns about postoperative pain and ambulation than whites. The authors
also found joint replacement itself to be less well known to African-Americans. Similar to the
findings in the CDC article, disparities were found related to knowledge and what to expect after
surgery.
Differences in knowledge, attitudes and beliefs regarding TKR may have an influence on
this disparity. Low outcome expectations as a result of communication gaps with health care
providers or inaccurate information from peers may have an effect. Culturally sensitive
educational resources must be developed and available for providers and their patients so this
health disparity can be overcome.
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As a regional referral site the facility performs a higher volume of joint replacement
surgeries, and already demonstrates low infection rates without MRSA decolonization. While
temporary decolonization may decrease the risk of infection during the perioperative period, this
action in and of itself will not address racial disparity and joint replacement. As stated above,
providers must have an awareness of and be culturally sensitive when discussing this topic with
African-American patients.
Social justice and Catholic teachings. The U.S. Conference of Catholic Bishops
(USCCB) offered this “Pastoral Reflection on Lay Discipleship for Justice in a New Millennium
1998:
Catholicism does not call us to abandon the world, but to help shape it. This does not
mean leaving worldly tasks and responsibilities, but transforming them. Catholics are
everywhere in this society. We are corporate executives and migrant farm workers,
senators and welfare recipients, university presidents and day care workers, tradesmen
and farmers, office and factory workers, union leaders and small business owners. Our
entire community of faith must help Catholics to be instruments of God's grace and
creative power in business and politics, factories and offices, in homes and schools and in
all the events of daily life. Social justice and the common good are built up or torn down
day by day in the countless decisions and choices we make. This vocation to pursue
justice is not simply an individual task -- it is a call to work with others to humanize and
shape the institutions that touch so many people. The lay vocation for justice cannot be
carried forward alone, but only as members of a community called to be the "leaven" of
the Gospel. (2013, paragraph 10).
We are invited to expand and grow social justice in organizations from the inside through
systems change.
The Joint Commission (2010), a hospital accreditation organization, developed the
monograph: Advancing Effective Communication, Cultural Competence, and Patient-and
Family-Centered Care: A Roadmap for Hospitals. This document is designed to assist hospitals
in meeting the particular needs of each patient regarding language, culture, health literacy, other
communication barriers, mobility needs and concerns of lesbian, gay, bisexual and transgender
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populations (Joint Commission, 2010). Practice examples are included in addition to
recommendations, with chapters identifying these specific points along the continuum of care:
admission, assessment, treatment, end-of-life care, discharge and transfer, and organization
readiness (Joint Commission, 2010). The important theme of patient centered care is supported
throughout this monograph from the perspective of social justice.
Conclusion. This project addresses the responsibility of pursuing social justice.
Decolonization may prevent infection and further complications, even death, that could result
from a SSI. Implementing decolonization may increase the likelihood of a quality health
outcome that will impact psychological, spiritual, and physical aspects of care for patients.
Quality health outcomes not only contribute to patient satisfaction, but affect the psychological,
spiritual and physical well-being of family members who are instrumental in supporting the
patient at the time of surgery as well.
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Chapter 2

Theoretical Frameworks
This chapter will discuss two models that were selected to support the project as a
theoretical framework. One model is grounded in the field of social and behavioral science, and
was chosen as an approach to encourage and sustain staff from the various disciplines to
participate fully in the project (Kurt Lewin’s Change Theory). The second model supports
preventive health behaviors and was selected to motivate and positively influence patients to
complete the decolonization process following discharge from the hospital (Nola Pender’s
Health Promotion Model).
The chapter will further address the clinical questions in PICO design (patient population,
intervention, comparison group, and outcome) that formulated the basis of the project. A review
and synthesis of literature that is relevant to MRSA decolonization, orthopedic surgery, surgical
site infection and total hip/total knee arthroplasty is included in the chapter as well.
A theoretical framework provides guidance as a project evolves. The end results will
determine whether the knowledge learned from implementing a project should create a change in
practice (Sinclair, 2007). The theoretical framework of this project relies on Nola Pender’s
Health Promotion Model (HPM) and Kurt Lewin’s Change Theory. Both theories are applicable
to the project, one relative to the patients and one to the health care workers. Pender’s model
will directly affect the patient participation component of MRSA decolonization. Lewin’s model
will be utilized to facilitate the change in work practices for health care workers. It is necessary
for both groups to engage in this project if the goal of temporary MRSA decolonization and
prevention of SSIs will be achieved.
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In the Health Promotion Model (HPM), Pender contends that nurses can assist people to
care for themselves and achieve self-efficacy (1996). Nurses can accomplish this by recognizing
the complex biological and psychosocial processes that motivate people to participate in
behaviors that will improve health (Pender, 1996). A diagram of Pender’s model (Appendix A)
flows from left to right, structured in three columns or pillars representing individual
characteristics and experiences, behavior specific cognitions and affect, and behavioral outcomes
(Pender, 1996).
Pender’s model has fourteen assertions. Two of the assertions in particular apply to this
project. One is that “persons commit to engaging in behaviors from which they anticipate
deriving personally valued benefits” (as cited in Sakraida, 2002, p. 630). A second assertion is
that “perceived competence or self-efficacy to execute a given behavior increases the likelihood
of commitment to action and actual performance of the behavior” (as cited in Sakraida, 2002, p.
630). Applying mupirocin to one’s nares to decolonize MRSA in the postoperative period which
will be required of participant’s in this systems change project demonstrates an individual’s
commitment to a plan of action and health promoting behavior. The positive health outcome will
be temporary MRSA decolonization and possible prevention of a MRSA SSI.
Kurt Levin’s Change Theory (Nursing Theories, 2011) is a second theoretical framework
applied to this SCP. Burnes (2004) asserts that although Lewin developed this three-step model
over 60 years ago, it continues to be a commonly cited framework to support successful change
projects. The three steps are unfreezing, moving and refreezing. Lewin determined in Step 1,
unfreezing, that human behavior is held in equilibrium by driving and restraining forces. He
believed this equilibrium needs to be disrupted in order for change to occur (Burnes, 2004). Old
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behaviors would need to be rejected and replaced by new, thus his use of the term unfreezing
(Burnes, 2004; Medley & Akan, 2008).
Step 2 or moving, involves learning. Learning includes knowledge of what the possible
options are and moving on from previous behaviors to new behaviors which will enable the
planned change to occur. Assessment and reinforcement are necessary during this step, or it is
possible that the change may be temporary (Burnes, 2004; Medley & Akan, 2008).
In Refreezing or Step 3 the new equilibrium is established. New behaviors are sustained
and it is posited that old behavior will be unlikely to be resumed (Burnes, 2004). It would be
expected that innovative work practices would be fully implemented as part of a system change
project during this step in the change process (Medley & Akan, 2008).
Lewin’s model is relevant to this system’s change project in several ways. Unit nurses
will be responsible for identifying on the lab request that a patient is being admitted for a THA or
TKA. When a patient’s admission MRSA swab is positive the CRNA will be responsible for
notifying the surgeon to order vancomycin rather than cefazolin, and in addition to order
mupirocin to begin decolonization. Applying Lewin’s model may assist in promoting
acceptance of these changes and limit resistance from the health care providers.
Literature Review and Synthesis
Prior to beginning the literature review two PICO questions were formulated. The first
PICO question associated with this literature review was: In adult patients undergoing total hip
and total knee arthroplasty, what proportion of MRSA positive patients can be temporarily
decolonized when compared to the standard of care (no decolonization)? A second PICO
question associated with this literature review was: In adult patients undergoing total hip and
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total knee arthroplasty, does decolonization of MRSA positive patients reduce surgical site
infection when compared to the standard of care (no decolonization)?
Database Search/Articles Selected
The National Library of Medicine Medical Subjects Headings (MeSH) browser was used
to review and to relate chosen descriptor words. Key search terms included: MRSA,
decolonization, orthopedic surgery, surgical site infection and total joint arthroplasty. The
databases utilized for journal searches from 2007-2012, were CINAHL and PubMed. Articles
selected were from peer reviewed journals. Limiters such as evidence based practice, English
only, human subjects, gender all, and adult age groupings were applied. Randomized controlled
trials (RCTs) and cohort studies were preferred for offering evidence-based practice. Cohort
studies were prevalent in the search and selected because the study designs and the findings
identified were comparable to the PICO question. Although review articles were included in the
search and were examined, they will not be incorporated into this paper. Exclusion criteria were
books/texts, and articles with heavy emphases on clinical microbiology, specific prosthetics, and
other MRSA related post-operative complications. Articles selected for this literature review are
included in the Table 1 (Appendix B).
Critical Analysis of Evidence Related to the Clinical Question
Literature or articles. Overall the articles examine the impact of MRSA decolonization
on outcomes of patient care. More specific categorization identifies three subgroups: patients
screened for MRSA decolonization with the hypothesis that this would decrease SSI rates (Kim
et al., 2010; Hadley, Immerman, Hutzler, Slover, & Bosco, 2010; Price et al., 2008); screening
and factors associated with poor post-operative outcomes (Gupta, Strymish, Abi-Haidar,
Williams, & Itani, 2011; Yano et al., 2009); and factors influencing failure to decolonize
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(Buehlmann et al., 2008; Lee et al., 2011). The primary objective of Price et al. (2008) was to
determine the prevalence of nasal colonization with S. aureus. Prevalence, an important factor in
decision-making about per-screening and decolonization, was quantified in another of the earlier
articles (Buehlmann et al., 2008) and one of the most recent (Lee et al., 2011). Knowledge about
prevalence influences positive patient outcomes and can impact resource utilization.
Population/sample. Patients sampled in five of the seven studies included preoperative
patients scheduled for elective surgery (Kim et al., 2010; Gupta et al., 2011; Yano et al., 2009;
Hadley et al., 2010; Price et al., 2008). Four of the five studies focused on orthopedic patients.
Gupta et al. (2011) included all surgical subspecialties at a Veterans Affairs hospital except
dental and ophthalmology. The patients sampled in the remaining two studies included
hospitalized patients, not necessarily scheduled for surgery. All studies used a convenience
sample of consecutive patients. Only Gupta et al. (2011) described the patients selected as
having clean or clean-contaminated wound classes. The other authors may have assumed
common knowledge that most index orthopedic procedures are clean cases. Wound
classification is an important defining term for all surgical subspecialties. Clean and cleancontaminated wound classifications are not considered a risk factor for SSI (Mangram, Horan,
Pearson, Silver, & Jarvis, 1999).
Research designs. Four of the studies utilized a prospective cohort study design (Kim et
al., 2010; Yano et al., 2009; Hadley et al., 2010; Buehlmann et al., 2008), one (Gupta et al.,
2011) a retrospective design, one a case control design (Lee et al., 2011) and one a crosssectional design (Price et al., 2008). Kim et al. (2010) used historical controls. Five of the
studies occurred in hospital setting (Kim et al., 2010; Gupta et al., 2011; Hadley et al., 2010;
Buehlmann et al., 2008; Lee et al., 2011). Yano et al. (2009) and Price et al. (2008) screened
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patients in the community setting during pre-operative outpatient clinic appointments. While
this strategy is useful for identifying community trends, patient characteristics may not be similar
to those in the hospital setting.
Interventions. Three of the seven studies reviewed included an intervention (Kim et al.,
2010; Hadley et al., 2010; Buehlmann et al., 2008). All interventions included 2% mupirocin
ointment to the nares BID x 5 days. Kim et al. (2010) added 2% CHG showers x 5 days, and
Hadley et al. (2010) a single CHG (2% or 4% not specified) shower on the day of surgery. The
most comprehensive/complex intervention by Buehlmann et al. (2008) included 2% mupirocin to
the nares BID x 5 days, oral rinsing with 2% CHG TID, daily body washing with 4% CHG, and
oral antimicrobials once or twice daily depending on the site for urogenital and gastrointestinal
decolonization. Perioperative vancomycin was used by Kim et al. (2010) and Hadley et al.
(2010) for better MRSA coverage rather than cefazolin. Vancomycin was given perioperatively
in some of the cases analyzed by Gupta et al. (2011). The type of case was not detailed but was
adjusted for in the analysis. Buehlmann et al. (2008) ordered oral vancomycin for patients
requiring gastrointestinal decolonization. This study did not focus on surgical patients, but
hospital patients overall.
Comparisons. Only two of the seven studies used a case-control design so comparison
was not possible. Kim et al. (2010) utilized a historical control group for comparison that
immediately preceded the study group. This close temporal association may have reduced
confounding that occurs with historical controls related to changing demographic characteristics
over time. Hadley et al. (2010) identified a control group by selecting those patients who did
not participate in MRSA screening before surgery. This may influence results. Bias exists
because these patients self-selected out of the opportunity for screening. Kim et al. (2010)
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compared SSI rates between carriers and non-carriers during the study period, giving some
insight into the non-intervention, non-historical control subjects in the study group, rather than
only comparing with the historical controls. All participants in the study were matched by age
and gender. Buehlmann et al. (2008) compared the proportion of patients positive on admission
to those positive following decolonization. There was no control group. Without a control
group the results may have been influenced by extraneous variables. Lee et al. (2011) compared
characteristics of the cases to controls to determine factors influencing persistent MRSA
colonization related to mupirocin and CHG use.
Outcome Measures. Decolonization of patients who were MRSA positive on admission
and the effect on SSI rates was described in five of the studies (Kim et al., 2010; Gupta et al.,
2011; Yano et al., 2009; Hadley et al., 2010; Price et al., 2008). In each of these studies SSIs
were determined using the standard National Healthcare Safety Network (NHSN) surveillance
definitions. These definitions limit an SSI to within 30 days past surgery, or up to one year from
surgery if the case involved an implant. In addition, the definitions determine the depth of the
infection: superficial, deep, or organ/space. A superficial infection cannot occur after 30 days
from the day of surgery.
Carrier status following decolonization was an outcome measure included in three of the
studies (Kim et al., 2010; Buehlmann et al., 2008; Lee et al., 2011). Age, previous
hospitalization, and antimicrobial use were some of the variables associated with persistent
colonization. Age is also a factor associated with the need for joint implant surgery. The risk of
an SSI may be reduced for an older person having joint replacement surgery if decolonization is
successful in the presence of these variables. Buhlmann et al. (2008) reported decolonization
was “highly effective” when patients completed the entire course of treatment. Completion of
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decolonization treatment may be more easily accomplished within the hospital setting where it is
essentially a directly observed therapy.
Results. There was a significant decrease in SSI rates with decolonization in the studies
conducted by Kim et al. (2010), Gupta et al. (2011) and Hadley et al. (2010). Kim et al. (2010)
found the SSI rate during study period lower than in control period (59% reduction rate,
p=0.009). Gupta et al. (2011) found a positive pre-op MRSA culture significant for positive
post-op culture (p<0.001), for a MRSA SSI (p=0.01), and for other post-op infections (p<0.01)
unadjusted. Yano et al. (2009) found one is 11 times more likely to have an MRSA SSI if
prescreening was positive (adjusted OR 11.0, 95% CI (3.0-37), p<0.001). Lee et al. (2011)
found age, combined mupirocin and CHG resistance, hospitalization within two years,
wounds/ulcers, MRSA inactive antibiotic use, and central lines to be independent risk factors
associated with persistent colonization and decolonization failure. The study by Price et al.
(2008) revealed 30.3% subjects (86/284) to be colonized with S. aureus, five of which were
MRSA (6%). Of the 284 patients screened in two years, 1.8% were colonized with MRSA.
Buehlmann et al. (2008) found decolonization completed in 87% (54/62) patients with a mean of
2.1 and a SD±1.8.
Validity is a question in the study by Hadley et al. (2010). From the results section
(Hadley et al., 2010, p.2) in the article:
During the study period, 2058 patients were included in the study. There was complete
follow-up in this retrospective study of prospectively collected data. The total number of
treatment patients was 1644 patients (80%) and 414 (20%) in the control group. At the
onset of the study the proportion of the preadmission testing (PAT) treatment group was
roughly equal. However as the study progressed the protocol was quickly adopted by all
surgeons and the non-PAT patients decreased significantly.
The treatment group had approximately four times the number of patients as the control group.
Only deep SSIs were reported in the outcome data, superficial and organ/space (joint) infections
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were not. The reported 13% decrease in deep SSIs in the treatment group versus the control
group was not significant at the reported p value of 0.809, but does represent a favorable trend.
There was no discussion about adjusting statistically for the confounder of surgeons adopting the
protocol outside of the study parameters.
Synthesis of the Evidence Related to the Clinical Question.
These studies have clinical significance because MRSA decolonization in adult patients
undergoing total hip and total knee arthroplasty may reduce SSIs when compared to the standard
of care. Decolonization has not been recommended in the past except in outbreak situations or
for use with specific populations, in this case adults scheduled for elective joint replacement.
The articles assembled in the literature review contain evidence suggesting that
prescreening and eradication of nasal MRSA is a practical action to consider. It has been
previously stated that SSIs increase morbidity and mortality. Yet, SSIs are preventable and one
approach may be prescreening and decolonization. All articles that discussed decolonization
favored it. Five of the seven articles reviewed were specifically written to address
decolonization and SSI prevention in patients scheduled for orthopedic surgery. Completing the
full treatment course was noted to make decolonization “highly effective” by Buehlmann et al.
(2008, p. 501), although the article was not written related to orthopedic surgery, but to overall
hospital admits.
The study by Lee et al. (2011) cautioned against widespread use of the antimicrobial and
skin disinfectants. The authors found resistance to those products significantly increased the risk
for persistent nasal MRSA colonization following treatment to eradicate it. It is noted in the
article that the study site had been using mupirocin and CHG to decolonize patients since 1994
(Lee et al., 2011, p. 1423). Antimicrobial stewardship is a large part of the mission of the
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Infectious Disease Section and an Antimicrobial Subcommittee at the facility where the project
was implemented. Decolonization and resistance always merits close monitoring.
In spite of the inconsistencies noted above there is sufficient evidence in the literature
reviewed for this paper to attempt prescreening and decolonization for adult patients undergoing
total hip and total knee arthroplasty. Prescreening and decolonization can be an effective
prevention strategy that may be adopted as a change in institutional protocol, and thus a change
in a system in the population served by this project. Surgeries involving implants are high risk
surgeries. Surveillance cultures for MRSA are collected on admission, transfer, discharge and
death under an existing directive at this facility. Decolonization and monitoring of infection is
more easily done because of this. MRSA decolonization as a part of a pre-operative protocol
could increase positive post-operative outcomes and assist in decreasing the MRSA burden
hospital wide.
Additional Evidence
National practice guideline review. The National Guideline Clearinghouse, Cochrane
Reviews, and the Association of Professionals in Epidemiology and Infection Control (APIC)
were accessed online in the search process. Search terms used included MRSA infection and
preventing surgical site infection as topics or diseases. Three related documents were found:
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of
Methicillin-Resistant Staphylococcus Aureus Infections in Adults and Children (Liu et al., 2011),
Guide to the Elimination of Methicillin-Resistant Staphylococcus aureus (MRSA) Transmission
in Hospital Settings (APIC, 2010), and the Guide to the Elimination of Orthopedic Surgical Site
Infections (APIC, 2010). Guideline documents selected for this literature review are included in
the attached Table 2 (Appendix C).
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The Guide to the Elimination of Methicillin-resistant Staphylococcus aureus (MRSA)
Transmission in Hospital Settings (APIC, 2010) addressed nasal decolonization. Decolonization
is not routinely recommended; but indicated for certain situations such as in an outbreak setting,
or to eradicate carriage in patients with recurrent infections, and in colonized MRSA patients
undergoing a surgical procedure identified as high risk for a MRSA SSI (APIC, 2010).
Decolonization was described as:
The use of a variation of the following regimen for adults: Nasal decolonization with 2%
mupirocin ointment applied to the nares twice a day for five days; AND, Skin antisepsis
with chlorhexidine or hexachlorophene for 5 days applied per manufacturer’s instructions
(APIC, 2010, p. 62).
The document reports decolonization may be indicated for patients undergoing surgeries
with implants including cardiac, orthopedic, vascular and neurosurgical procedures (APIC,
2010).
The Guide to Elimination of Orthopedic Surgical Site Infections (APIC, 2010) reports,
“Staphylococcus aureus, particularly MRSA, remains a significant pathogen in postoperative
orthopedic SSIs (APIC, 2010, p. 39). Decolonization is discussed as an option for orthopedic
surgery patients. The authors urge that decolonization strategies and protocols be standardized,
and suggest order sets and pathways as two potential ways of achieving this end (APIC, 2010).
The Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA)
for the Treatment of Methicillin-Resistant Staphylococcus Aureus Infections in Adults and
Children (Liu et al., 2011) is an evidence-based guideline providing recommendations for
management of MRSA infections in adult and pediatric patients. Multiple clinical syndromes are
discussed including bone and joint infections. Decolonization was not addressed related to
management of bone and joint infections. It was discussed concerning skin and soft tissues
infection. The authors report an association between mupirocin and a decrease in hospital-
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acquired S. aureus infections in patients undergoing surgical procedures or receiving dialysis
(Liu et al., 2011). The guideline lists recommendations for decolonization followed by a
summary of the evidence.
The IDSA guideline was appraised using the AGREE II online tool (Brouwers et al.,
2010) [Appendix D]. The document is succinct with clearly written definitions, and based on
evidence of best practice. A standard procedure was used by the IDSA panel to grade the
recommendations and weigh the quality of evidence used in the development of the guideline.
There was an external peer review of the draft document which was reviewed and approved by
multiple professional organizations These steps contribute to the validity and reliability of the
document and it’s applicability to the practice setting. Options and alternative treatments are
discussed demonstrating clinical flexibility.
There are some limitations to the IDSA guidelines. Although the domain of Rigour of
Development received the highest score at 46 points, PubMed was the only computerized
database searched for literature and the search was limited to English-language only. The
domain Stakeholder Involvement scored the lowest at 11 points. Patients and providers are
identified as the target population however no statement is included as to whether the views and
preferences of patients/public were considered while the document was being developed. It is
unclear whether multiple disciplines were involved in developing the document as the author’s
titles are not identified. No plans were offered for future review and update.
This guideline is recommended for providers. Guideline sections begin with a clinical
practice question followed by graded recommendations and a weighted quality rating. A
summary of recent evidence supporting the recommendation completes the discussion of each
question. Clinical applicability and patient-centered care are addressed throughout the
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document. There is also a statement about voluntary adherence to the guidelines. Providers are
encouraged to consider individual patients and specific clinical situations, recognizing that this
guideline is not the only option for providing quality patient care. Further, antimicrobial use is
not the only intervention that is recommended. Prevention education messages about personal
hygiene and wound care are included as suggested strategies. There is discussion about not
sharing or reusing personal items. Environmental hygiene measures are also described as
effective interventions for patients. At the close of the document a section on Research Gaps
examines areas of limited or conflicting data, and the need for additional research on certain
topics. The guideline is worth referencing when managing MRSA infections in adults and
children. It is valid, reliable and applicable to many practice settings.
Systematic reviews. Two systematic reviews will be addressed in this section:
(McGinigle, Gourlay, & Buchanan, 2008; van Rijen, Bonten & Kluytmans, 2008). These are
included in Table 3 (Appendix E). McGinigle et al. (2008), found evidence from several studies
that collecting ASCs decreases the incidence of MRSA infection. However, the authors
concluded that the evidence was of poor quality and reported no definitive clinical
recommendations could be made.
The objective of a review by van Rijen et al. (2011) was to determine whether the use of
mupirocin nasal ointment in patients identified with S. aureus nasal carriage reduced S. aureus
infection rates. In this review an extensive literature search focused on RCTs regardless of
language or publication status (Table 3, Appendix E). Nine RCTs were selected. Patient
population, interventions and outcomes are described in detail. Seven of the nine studies were
double-blind RCTs with four of the seven rated high quality for including blinding, intention-totreat, and report of loss to follow-up in addition to the double-blind. Bias was well controlled for
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in the study designs. The use of mupirocin in nasal carriers resulted in a statistically significant
decrease in S. aureus infections (van Rijen et al., 2008). Two studies were deemed low quality.
Outcomes were examined individually and combined across the studies when appropriate (Table
3, Appendix E). Applicability to clinical practice is articulated throughout this article, most
strongly in the authors’ conclusions. Their conclusions were reported as implications for
practice and implications for research. The practice implications concluded by the reviewers are
that in confirmed nasal carriers, mupirocin use should be considered in hospitalized patients
undergoing surgery or dialysis, and that limited use of mupirocin does not appear to be
associated with antimicrobial resistance (van Rijen et al., 2008). The research implication
gleaned from this systematic review is that the effectiveness of mupirocin is related to carriers
alone. Rapid tests to confirm and differentiate MRSA and Methicillin-Sensitive S. aureus
(MSSA) were discussed. These important diagnostic tools will enable providers to treat carriers
in real time, within hours as opposed to days using standard culture technique. Rapid tests also
influence proper antibiotic selection for patients (van Rijen et al., 2008).
Ranking and type/level of evidence. Three clinical guidelines, two systematic reviews
and three original research articles were ranked by level of evidence and quality. Level of
evidence criteria are taken from Melnyk & Finehout-Overholt (2011, p.12), and are listed below
Table 4 (Appendix F). Criteria used to assess quality are derived from the United States
Preventive Services Task Force (2008) which are also noted in Appendix F.
All documents examined MRSA colonization in one or more of four ways: identification
(screening), preventing, treating and eliminating (decolonizing). Discussion of decolonization
was common to all articles. While none of the authors supported routine decolonization, all
discussed it as part of an intervention program. Intervention programs are indicated for MRSA
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outbreaks or for certain at-risk populations (APIC, 2010; APIC, 2010; Liu et al., 2011, van Rijen
et al., 2008). The strength of the evidence for pre-screening and decolonization is low to
moderate and of fair quality (Table 1, Appendix B; Table 2 Appendix C; Table 3, Appendix E).
In part this is related to the lack of RCTs, a standardized decolonization protocol, concerns about
possible resistance to mupirocin, and lack of outcome data about reduction of infection rates (Liu
et al., 2011). Further research is needed to add to the body of evidence and address these
concerns.
Integration of literature review. MRSA decolonization in adult patients undergoing
total joint replacement may reduce SSIs. Recent studies (Kim et al., 2010; Yano et al., 2009;
Hadley et al., 2010; Price et al., 2008) favor prescreening and decolonization as a preventive
measure for patients scheduled for orthopedic surgery (Table 1, Appendix B). According to the
APIC Guide to the Elimination of Methicillin-resistant Staphylococcus aureus (MRSA)
Transmission in Hospital Settings (2010, p. 61), “Decolonization regimens may be indicated for
both nasal MRSA and S. aureus colonization in patients undergoing vascular surgery with
placement of a graft, total joint arthroplasty, and neurosurgical procedures with implantation of
hardware as well as other surgical procedures.”
The IDSA Clinical Practice Guidelines for the Treatment of Methicillin-Resistant
Staphylococcus Aureus Infections in Adults and Children do not offer recommendations for
decolonization related to orthopedic surgery or bone and joint infections, but do for MRSA skin
and soft tissue infections. The recommendation suggests decolonization with mupirocin twice
daily for 5-10 days as a strategy, and that it is offered with education and reminders about
hygiene (Liu et al., 2011). It is disappointing that the recommendation has a CIII rating which is
defined as “poor evidence to support a recommendation for or against use” as the “evidence is
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from opinions of respected authorities based on clinical experience, descriptive studies or reports
of expert committees” (Liu et al., 2011, p.52). This is of interest as the literature review and
analysis section for the IDSA document states: “There were few randomized clinical trials;
many recommendations were developed from observational studies or small case series,
combined with the opinion of expert panel members” (Liu et al., 2011). The basis for the IDSA
document is exactly what was identified as not supporting evidence-based practice.
In a Cochrane review, van Rijen et al. (2008) concluded that decolonization with
mupirocin in S.aureus nasal carriers resulted in a significant reduction in S. aureus infections.
This systematic review also found a significant reduction in infection rates in surgical and
dialysis patients in a subgroup analysis. However, when SSIs were analyzed as the primary
outcome the result was not statistically significant (van Rijen et al., 2008).
An additional finding of van Rijen et al. (2008) was that mupirocin resistance should not
be an issue following short-term intranasal use for surgical or dialysis patients. Caution is still
recommended related to this as Lee et al. (2011) reported genotypic CHG resistance alone did
not predict persistent MRSA carriage. CHG and mupirocin are often used simultaneously to
decolonize or eradicate MRSA. This suggests that a combination of low-level mupirocin and
CHG resistance may be required to result in failure to eradicate MRSA. Persistent colonization
was also discussed by Buehlmann et al. (2008). This group determined their standard
decolonization protocol was highly effective when the full treatment course was completed.
Their treatment regimen was complex, including intranasal mupirocin ointment, CHG mouth
rinse and CHG full-body washes, all applied for five days (Buehlmann et al., 2008).
Researchers continue to investigate MRSA decolonization. Many favor this approach for
certain patient populations. Prescreening and decolonization is a prevention strategy that could
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be easily implemented for orthopedic patients scheduled for total joint replacement. Reducing
MRSA SSIs is an important goal. Decolonization is an intervention to consider.
Summary of recommendations from the literature review. The summary
recommendation is: there is sufficient evidence in the literature to implement prescreening and
decolonization of MRSA in adult patients undergoing joint replacement surgery. Recent studies
(Kim et al., 2010; Yano et al., 2009; Hadley et al., 2010; Price et al., 2008) favor prescreening
and decolonization as a preventive measure for patients scheduled for orthopedic surgery (Table
1, Appendix B). Intervention programs are indicated for MRSA outbreaks or for certain at-risk
populations (APIC, 2010; APIC, 2010; Liu et al., 2011, van Rijen et al., 2008). A Cochrane
systematic review and APIC Guideline documents (Table 2, Appendix C) define orthopedic
surgery patients as at-risk populations for MRSA infection if colonized preoperatively (van Rijen
et al., 2008; APIC, 2010; APIC, 2010).
Implementation of the summary recommendation requires the following steps: 1)
collection of an admission nares swab to screen for MRSA (Appendix G); 2) the lab notifies the
anesthesia workroom (Appendix H); 3) appropriate antibiotic prophylaxis is administered
(vancomycin instead of cefazolin); 4) first dose of mupirocin is administered in the OR; 5)
postoperative mupirocin and vancomycin are ordered. Step 1) is required at the facility where
the project was implemented under an established policy. Step 2) is referenced in the system
review by van Rijen et al, “Recent technological advances in rapid diagnostics have provided the
ability to detect nasal carriage of S. aureus within hours rather than days which makes it possible
to treat nasal carriers rapidly” (2008, p. 14). Step 3) is referenced in the Guide to Elimination of
Methicillin-Resistant Staphylococcus aureus (MRSA) Transmission in Hospital Settings, “The
use of systemic antimicrobials for MRSA decolonization may be considered by the patient’s
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healthcare provider if deemed clinically appropriate” (APIC, 2010, p.62). Gupta et al. (2011)
reported the risk of vancomycin administration preoperatively in nares positive patients was
protective, but additionally state an association for this subgroup is not conclusive given the wide
confidence intervals for this variable.
Step 4) Successful decolonization beginning on the day of surgery as opposed to five
days preoperatively is being implemented. Liu et al. (2011) reported, “While awaiting guidance
from ongoing clinical trials, the Panel suggests mupirocin alone or a combined strategy of
mupirocin and topical antiseptics (e.g., chlorhexidine and diluted bleach baths) if decolonization
is being considered. The optimal dosage and duration of such regimens is unknown; suggested
dosages are based on several ongoing clinical trials” (2011, p. 18). Step 5) is supported by the
evidence from the literature addressed under Step 3).
Methicillin-Resistant Staphylococcus aureus SSIs have been identified as a risk to
patients colonized with MRSA, and planning joint replacement surgery (Kim et al., 2010; Yano
et al., 2009; Hadley et al., 2010; Price et al., 2008). This postoperative complication impacts
health outcomes for patients in terms of morbidity and mortality (Gupta et al., 2011).
Methicillin-Resistant Staphylococcus aureus SSIs also contribute to increased length of stay and
rising costs in health care (Anderson et al., 2009). Decolonization may be an additional strategy
to make total joint replacement surgery safer for patients.
Conclusion. The literature supports a systems change project that will implement a
program to preoperatively screen the nares of orthopedic patients presenting for joint
replacement surgery at the facility. Admission screening will identify the presence of MRSA.
Those patients with positive results will be decolonized prior to or at the time of surgery, because
they are at an increased risk of surgical site infections with a permanent implant. Mupirocin
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ointment will be the drug used for decolonization, and intravenous vancomycin will be the drug
given as preoperative antibiotic prophylaxis.
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Chapter 3

Project Design and Methodology
This SCP implemented a program to preoperatively screen the nares of patients
presenting for TKA or THA surgery at a Midwest teaching hospital. Screening identified
whether MRSA colonization was present or not. Those patients with positive results were
decolonized at the time of surgery, because they were at an increased risk of SSI as they were
undergoing surgery for a permanently implanted prosthetic device. The data was analyzed to
determine the differences between the two groups. Cases were compared to controls who
underwent the same procedure but who were not decolonized for MRSA, to determine whether
decolonization was a factor in preventing SSIs at 90 days postoperatively.
Data handling and record keeping. A proposal for this project was reviewed and
approved by the facility IRB. The St. Catherine University IRB reviewed the facility IRB file
and granted approval as well. A waiver for informed consent was obtained from the facility IRB
as part of the approval process. Since the project was a retrospective chart review it was not
possible to contact all the subjects to obtain consent. Chart review presented a minimal risk of
loss of confidentiality and an adequate plan was developed to protect identifiers.
Compliance with HIPPA regulations was met. Lists of subjects were coded. The links
for the coded lists were maintained in a locked cabinet in a double locked office available only to
the research team. Data was entered into a spreadsheet stored on a personal drive on a secure
computer. The computer was accessed with a personal identity verification card and password.
The facility’s firewall and all other security measures applied to the computer. When data was
shared with research staff a secure share drive was used. No conflict of interest was identified
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for anyone on the research team. When the data collection was completed and entered into the
spreadsheet, the identifying link to the subjects was destroyed.
Selection of subjects. The project was a retrospective case-control study of patients at
the facility who were MRSA screen positive preoperatively, began decolonization on the day of
surgery, and underwent total hip or total knee surgery from May 1, 2012 through May 1, 2013.
Cases were identified from a convenience sample of 299 patients undergoing THA or TKA
surgery during the same time period. The controls were selected from patients undergoing THA
or TKA surgery at the facility from May 1, 2009 through September 1, 2011. Controls were
matched by age (+/- three years), gender (M/F), type of procedure (THA/TKA), and location of
the surgery (right/left side of the body).

Age inclusion criterion for cases and controls was that

patient be 18 years of age or older. While randomization of subjects was not directly applied in
this project, the historical controls were selected from a database that does utilize a
randomization process.
Project intervention. Admission nares swabs were submitted to the Microbiology lab.
Analysis was performed utilizing Polymerase Chain Reaction (PCR). PCR analysis is only
utilized for admission nares swabs at the facility unless specifically ordered otherwise.
Specimens were collected using Copan swabs. The Cepheid GeneXpert® Infinity-80 System is
the analyzer that will be employed by laboratory staff to determine the results of the nares swabs.
Mupirocin ointment was the drug used for decolonization, and intravenous vancomycin
was the drug given for pre-operative antibiotic prophylaxis. Mupirocin was applied twice a day
to the patient’s nares for a total of five days. The initial dose was applied by a certified
registered nurse anesthetist (CRNA) in the operating room. Nursing staff or patients themselves
applied the mupirocin twice a day for the three days on average that the patient was hospitalized.
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The patients continued applying the mupirocin two times daily for the remaining two days at
home to complete the total of five days.
Observations and definitions. Chart review was used for data collection. Data
collection included demographics, details of antibiotic use, surgery type and conditions,
laboratory results, comorbidities and type of surgical site infection. Secure facility approved
computer access was used to review the electronic medical record. Patient data were identified
by a coded number to protect confidentiality.
SSIs were identified using definitions and criteria from the CDC NHSN, “Surgical Site
Infection (SSI) Event” portion of the “Procedure-associated Events” section of the National
Healthcare Safety Network (NHSN) Manual Patient Safety Component (CDC NHSN, 2013).
Definitions from the Veterans Affairs Surgical Quality Improvement Project (VASQIP) were
used with permission as criteria for all other variables (Mark A. Wilson, MD, personal
communication, July 7, 2012).
Subject population for analysis. The estimate for enrollment size was based on the
number of total hip and total knee surgeries seen per month in fiscal year 2011. The projected
number was predicted to be between 300 and 330 patients. Case subjects were compared to
control subjects undergoing the same procedure, but who were not decolonized for MRSA. The
study was terminated following the collection and analysis of the data.
Statistical analysis. Characteristics of cases and controls were compared on categorical
variables using Chi-square statistics. Fisher Exact tests were used when expected cell
frequencies are less than 5. For continuous variables, independent group t-tests were be used for
comparisons. Evaluation of change in infection rates pre to post surgery was done using the
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Wilcoxon test. For those cases or controls with colonization pre surgery, Chi-squared tests, and
logistic regression, when possible, were used to examine predictors of infection postoperatively.
Introduction of an unforeseen confounder. A confounding factor was introduced four
months prior to the completion of the project. Another study was implemented using the same
patient population, patients undergoing THAs and TKAs, but with a different intervention. This
may have introduced potential for bias, although it is unlikely.
Evidence-based Project Implementation Plan
Timeline. The timeline for the project was May 1, 2012 through May 1, 2013. Case data
was collected retrospectively following those dates using chart review for known MRSA positive
or patients positive for MRSA on admission and undergoing THA or TKA surgery during that
period of time. Control data was collected using retrospective chart review of patients
undergoing THA or TKA who were not MRSA positive preoperatively from May 1, 2009
through September 1, 2011. IRB approval for the project lasts for one year from the initial date
of approval until February 14, 2014.
Resources—personnel, technology, budget, return on investment (ROI). Quality
health care is of vital concern to individuals in the United States (U.S.) and to the country’s
economy. In 2008, per capita health care costs were $7,681, compared with individual costs of
$356 in 1970 (Weisfeld, 2011). During that same year the total cost of U.S. health care was $2.3
trillion, with payments coming from multiple sources such as private insurance, payment out of
pocket; and public funding from federal, state and local entitlement programs (Weisfeld, 2011).
Stone (2010, p. 30) reports: “In fact, healthcare spending is growing at a faster rate than that of
our economy overall.”
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An important source of health care expenditures is surgical site infection (SSI) following
total hip arthroplasty (THA) or total knee arthroplasty (TKA). Courville et al. (2012)
documented the cost of a total joint revision surgery related to a deep infection as being about
$100,000; 3-4 times the cost of an initial THA or TKA. Lentino (2003) reported the cost of a
THA or TKA SSI at approximately $50,000.
According to Lee et al. (2010), around 35% of Americans are carriers of Staphylococcus
aureus. The authors note colonization rates of Methicillin-resistant Staphylococcus aureus
(MRSA) of 0.4% to 20.6% have been reported in the literature and that orthopedic surgery
patients are at risk for MRSA SSIs (Lee et al., 2010). Decolonization is an existing strategy to
provide/supply THA and TKA surgery with a decreased risk of MRSA SSIs.
Kurtz, Lau, Watson, Schmier, and Parvizi (2012) note that in 2010, it was expected that
approximately 8,136 infections related to hip prostheses and 17,781 infections related to knee
prostheses would occur. Projections for 2020, suggest 16,584 infections related to THAs and
48,971 related to TKAs may develop (Kurtz et al., 2012). These figures translate into an
estimated cost to U.S. hospitals of nearly $1.62 billion in 2020 and an estimated cost of nearly $1
billion by 2014 (Kurtz et al., 2012). The trend has been that each year individuals, private and
public health care organizations and insurers face scarcer resources. In addition, the Patient
Protection and Affordable Care Act (PPACA) will result in 32 million more Americans having
health insurance (Knickman, 2011).
An expectation is that more Americans with health insurance will create an increased
demand for health services overall, two of which may be THA and TKA surgeries. This effect
would demonstrate moral hazard, electing to have a surgery one may not have had in the past
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when uninsured. If having health insurance is viewed as a type of income increase, the demand
for surgical services will likely increase as well.
The goal of this systems change project was to determine the short term success of
MRSA decolonization beginning on the day of surgery, and to determine whether decolonization
at the time of surgery was effective in reducing the rate of SSIs for patients having THA or TKA
surgery at a Midwest hospital as a quality improvement project. The nares of patients admitted
for THAs or TKAs at the facility were swabbed to identify the presence of MRSA. This
screening was not a new expense as it has been done for all facility patients on admission,
transfer, discharge and death since 2006. Patients with newly positive MRSA results and known
positive patients were decolonized at the time of surgery because they were at increased risk of a
MRSA SSI by undergoing surgery resulting in a permanent implant. Mupirocin ointment was
the drug used for decolonization and intravenous vancomycin was the drug given for
preoperative antibiotic prophylaxis. The patients’ nares were also swabbed at discharge, again,
not a new expense as done for all discharges since 2006. The results of the swabs were
compared to determine temporary decolonization. Surveillance for THA and TKA SSIs was
done for 90 days postoperatively.
The market for this project consisted of patients electing to undergo THA or TKA
surgery at the facility (buyers) and the interdisciplinary group of health care providers involved
in orthopedic surgery at the facility (sellers). Decolonization was not “new” technology per se,
but could be viewed as a supply shifter related to increasing the quality outcomes associated with
THA/TKA surgery. More positive outcomes would likely increase the supply of these surgeries.
Fixed costs associated with this project were the number of patients having THA/TKA
surgery (which does not change greatly from year to year), utility costs, and software used
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related to the electronic health record. Some variable costs include medical supplies for lab
work, drugs and the cost THA/TKA prostheses. The need to quarantine instrumentation was a
variable cost. Vendors may or may not be on a tight schedule providing instrumentation to
multiple hospitals.
THA/TKA surgery has associated direct medical costs including imaging and prosthetic
devices, and direct nonmedical costs such as copays and other out of pocket expenses. There are
also intangible costs to the patient such as anxiety, localized pain, deconditioning and decreased
mobility related to the procedure. There are indirect costs such as lost work and family time.
Project costs are listed in Table 5, the cost spreadsheet (Appendix I). Included are the
costs of developing the protocol and templates for the project, staff education (such as time for
employee attendance and for the educator), and initial administrative costs. There were no
program material costs, room rental costs, or travel and lodging costs. Project benefits are
measured in terms of avoided costs: admission and discharge labs (Appendix J) are routinely
collected at the facility; and averted costs: the estimated cost of a single THA/TKA SSI. An
explanation of the ROI calculation, which was favorable, is found in Appendix K. Generally, if
the calculated ROI of a project is greater than zero it is considered reasonable to proceed with the
project.
A present value calculation was not discussed with stakeholders during the project
development process but was examined for this paper. Appendix L contains a representation of
present value over a five year time period assuming the medical cost avoided is $50,000, if one
SSI is prevented. This would amount to $216,473.83 in savings in present value terms.
Continuous quality improvement was well served by the implementation of this project.
Patients colonized with MRSA received a more appropriate prophylactic antibiotic and were
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attempted to be temporarily decolonized during the perioperative and immediate postoperative
period when the risk of SSI is the greatest. Decolonization of MRSA positive THA/TKA
patients not only decreased the risk of SSI for the project patients but decreased the MRSA
burden in the hospital overall as well with temporary decolonization.
Preventing infection is about quality of care and patient safety. It can also be about costs
avoided/averted, loss reduction (e.g., decreased length of stay) and even profit. Decisions are
made about projects such as this one and strategies are implemented. Outcome evaluation data
determines whether expectations are met. This cost benefit analysis is an attempt at making a
business as well as a clinical case for preventing SSIs through the use of screening and
decolonization.
Support from site. The facility had the resources to support the decolonization project.
However, although the hospital epidemiologist, the chief of surgery, and the chief of orthopedics
were in favor of the project, a limitation was that the residents rotate approximately every two
months which impacted continuity of the project. The chief of orthopedics and the orthopedic
nurse coordinator included education about this protocol during the resident orientation and
emphasized the importance of adherence to the protocol. The protocol itself was added to the
orthopedic resident handbook. This action added to the project’s feasibility. The scalability of
the project involved the orthopedic team, one nursing unit pre and postoperatively and the
operating room staff assigned to THA/TKA surgeries.
This project was considered a pilot study. It has been continued beyond the pilot phase
as there is an increasing body of evidenced-based literature to support preoperative MRSA
decolonization (van Rijen et al., 2008; Lonneke et al., 2010; Courville et al., 2012; Lee et al.,
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2010). Costs should not expand greatly beyond increases for drugs and lab related to those
described in Appendices I, J, and K.
Ethical considerations. Universal screening was implemented to determine the MRSA
status of patients. In order to meet a standard informed consent, patients were allowed to make
the choice about whether or not to consent to a treatment or procedure. This applied to MRSA
screening on admission. The universal screening strategy was implemented under an existing
directive, which ensured the risks and benefits of the screening procedure were discussed with
every patient on admission. This discussion included how the results of the swabs were used,
and how the results when positive affect patient care, for example, contact precautions were
implemented. The MRSA screening program promoted the principle of the greatest good for the
greatest number of people as one part of a bundled approach to decrease the MRSA burden
facility-wide and thus decrease the risk of transmission for patients who were not MRSA
colonized. Careful consideration of these measures established safe, quality patient care within
the practice of active MRSA surveillance.
Conclusion. Many of the human and financial assets required for this project were
already in place at the facility. Positive outcomes from this project should conserve existing
resources. Reductions in length of stay may occur, related to a decrease in SSIs. The overall
facility burden of MRSA should decrease. Mortality may decline as well. Successful
decolonization has the potential to result in improved patient-centered quality care and a
favorable return on investment.
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Chapter 4

Data Analysis.
During the study period 299 patients underwent THA or TKA procedures. Ten (3.5%) of
299 patients were positive on admission for MRSA. Four historical controls were selected for
each case for a total of 40 controls. Controls were matched by age, gender, type of surgery, and
location of surgery. Only one control was MRSA positive on admission.
Project Evaluation: Evidence-based Methodology and Analysis. Comparisons were
made between the 10 cases who underwent decolonization for MRSA and 40 control subjects
who did not. By definition all 10 of the cases were positive for MRSA prior to surgery. One of
the control subjects was positive for MRSA on admission. The remaining 39 controls were not.
All subjects were male and were operated on during the day of admission. None had acute renal
failure, were on dialysis, or had chronic obstructive pulmonary disease (COPD). The mean age
was 62.9 and mean body mass index (BMI) was 31.9 (Appendix M).
Chi-squared tests were used to compare the two groups on surgery type, surgery side,
duration of surgery, ASA score, length of pre-operative stay, type of pre and post-operative
antibiotic used, use of mupirocin, diabetic condition, tobacco use, preoperative albumin level,
use of tranexamic acid, history of MRSA infection/colonization, MRSA colonization at
discharge, SSI identified at ≤ 30 days from surgery, and at ≤ 90 days from surgery (Appendix N).
Findings (Appendix O) showed that case patients were significantly more likely than the
control patients to have a history of MRSA colonization/infection prior to admission for surgery
(Fisher’s Exact=.001), and no MRSA colonization at discharge (Fisher’s Exact=.022). There
was a significant difference in pre-operative antibiotic use, with 85% of control patients
receiving cefazolin and 70% of case patients receiving vancomycin (Χ²(2)=32.8, p<.001). Use
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of mupirocin was also significantly higher in case subjects at 70% compared with no use in
control patients (Χ²(1)=32.6.p<.001). Only case patients received tranexamic acid (40%), while
none of the control subjects did (Fisher’s Exact=.001). Finally, 80% of the control subjects were
receiving no treatment for diabetes where 80% of cases were receiving either dietary or
medicinal treatment for diabetes (Χ²(3)=15.0, p<.002). No other significant differences were
observed. Analyses of variance found no difference in age or BMI across the groups.
MRSA colonization in the cases was reduced from 100% to 30% pre to post surgery
(Wilcoxon Signed Ranks Z=2.65, p=.008). The impact of tranexamic acid on postoperative
colonization was also examined. No significant difference was found with use of tranexamic
acid among those colonized postoperatively and those not colonized. Observation of site
infection at 30 and 90 days postoperatively found only two patients, both controls, with a SSI.
One SSI was revealed at postoperative day 10 and one at postoperative day 82. Different
pathogens were identified.
Conclusion. Of the 11 patients with pre-operative MRSA colonization various predictors
of postoperative infection were examined. However, the small sample size precluded
meaningful inferential statistical tests related to these variables. Descriptively, two of the three
patients with MRSA colonization on discharge had knee surgery lasting over two hours. Two of
the three patients remaining colonized on discharge also received cefazolin rather than
vancomycin postoperatively. Only one of the three patients remaining colonized on discharge
received mupirocin. Two of the three colonized on discharge received tranexamic acid in the
perioperative period.
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Chapter 5

Discussion of Findings and Outcomes
Nasal colonization of MRSA may increase the risk of SSI in patients undergoing total
joint replacement surgery such as THA or TKA. A growing body of literature exists related to
the topic of MRSA and SSI as a complication of Orthopedic surgery (Kim et al., 2010; Gupta et
al., 2011; Yano et al., 2009; Hadley et al., 2010; Buelmann et al., 2008). There is evidence in the
literature supporting preoperative decolonization for patients planning to undergo surgery with a
permanent implant.
While there is evidence favoring preoperative decolonization, no standard protocol exists.
Much of the literature describes beginning the decolonization process at five days before surgery.
This project sought to determine whether patients scheduled to undergo THA or TKA surgery
could be temporarily decolonized by implementing a protocol beginning on the day of surgery.
The project also examined whether patients were identified with a SSI within the postoperative
period as defined by the NHSN. Demographic data, procedure-related data, and other risk factor
data potentially associated with SSIs were also examined.
Some difference between the cases and controls varied widely when considering
particular variables. While 50% (5/10) of the cases had a history of MRSA
infection/colonization prior to admission for surgery, none of the controls (0/40) did. Because
historical controls were used, only eligible case patients received tranexamic acid in the
perioperative period. Eighty percent of the cases were found to use dietary restrictions, oral
medications, or insulin injections to control diabetes; while 80% of the controls did not as they
did not have a diagnosis of diabetes. No SSIs were identified from 0 to 90 days in the cases.
Two SSIs were identified from 0 to 90 days in the control group.
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There was no difference in mean age (62.9 years) between the cases and controls as
matching age within three years was one of the selection criteria for controls. BMI data was very
similar for both groups with the mean BMI for the cases at 33.19 kg/m², and at 31.67 kg/m² for
the controls. There were no odds ratios to examine because the small number of observations
prohibited a regression analysis. An additional factor of interest that was not significant, yet
emerged from the analysis was that 100% (10) of the cases had an ASA score of 3, while only
two-thirds of the controls 67.5% (27) of the controls were assigned an ASA score of 3.
The findings of this pilot project suggest that beginning decolonization on the day of
surgery may be a reasonable approach given that 7 of the 10 cases had negative MRSA swabs at
discharge. Project results also demonstrate the need for further research about the benefits of
MRSA decolonization related to THA and TKA surgery and preventing SSI. In addition, the
findings lend support to the preliminary work and outcomes of other researchers such as
Buehlmann et al. (2008), who found that MRSA decolonization was successful when individuals
completed the full treatment course. It may be that beginning decolonization on the day of
surgery and continuing the process while the patient is hospitalized creates a supportive
environment that assists the patient in obtaining a positive outcome.
The results of this project are also consistent with those of Kim et al. (2010), who found
that it is feasible to implement a facility-wide prescreening program to identify and eliminate
MRSA colonization in patients undergoing orthopedic surgery. In addition the authors found a
significant decrease in SSIs. That finding was not demonstrated with this SCP as the limited
number of subjects prohibited such a statistical analysis.
Methodological issues must be addressed to guide similar projects about decolonization
in the future. Since the convenience sample was limited to only one Midwestern teaching
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hospital, the findings are not generalizable to patients in all hospital settings. A possible solution
would be for multiple hospitals from different regions to participate in a similar study to assist in
overcoming this limitation. Access to a larger sample size would also make a significant
contribution towards obtaining meaningful results.
Another factor to consider when developing a future proposal would be to include a
screening swab at a three or four month postoperative appointment to determine the
sustainability of the temporary decolonization. This knowledge is of importance to Infection
Preventionists as NHSN SSI surveillance for THA and TKA procedures now extends for 90 days
rather than the previous one year following a procedure (CDC, 2013). With large enough sample
sizes it may be possible in the future to examine whether there is an association between
decolonization and prevention of MRSA SSIs.
While no effect was demonstrated statistically related to this project, the concurrent study
with the same patient population must be addressed as an unforeseen confounding factor.
Communication among investigators about other active or proposed studies is critical in avoiding
the addition of such a confounding factor. Close inter-relationships may result in both variables
appearing weaker and unnecessarily compromising results.
Conclusions
Patient safety and satisfaction, evidence-based quality care outcomes, costs of an SSI,
and making good use of scarce resources were the driving forces for change with this project.
The system change of decolonizing THA and TKA patients on the day of surgery appears to
have been successful although the number of cases was small. A multidisciplinary group led by
nursing was required to establish, implement, and support the change. The protocol continues to
be used and was included in the handbook that is distributed to orthopedic residents at the
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facility. Despite the limitations encountered with this project, the results may be useful in
stimulating other hypotheses for future research.
Recommendations
DNP as a consultant. A doctoral prepared nurse has the ability to define and propose
changes to administrators within the organization. This recommendation should enhance the
consultation role within organizations in various clinical areas, with a critical eye toward
scrutinizing standards of care. One example is forming and leading multidisciplinary teams to
revise protocols and policies such as the MRSA decolonization project for patients undergoing
THA and TKA procedures. The evidence-based change in practice of MRSA decolonization
better serves the patient, potentially leads to both a quality and cost beneficial health care
outcome by reducing the MRSA burden in the facility and possibly preventing SSIs. Activities
such as this not only demonstrate the DNP’s skill at collaboration, but create an opportunity to
advance the field of nursing by sharing and gaining new knowledge from colleagues in other
disciplines.
It is also recommended that DNPs in a consultative role continue to not only maintain,
but augment skills related to information technology and virtual environments. These essential
skills for searching and reviewing literature, mining data, performing statistical analyses,
performing evaluations, providing health education, and for communication in general call for
lifelong learning. Utilizing health informatics increases opportunities for telemedicine contact
with patients and web-based conferencing, education, and mentoring opportunities for nurses as
well.
A final recommendation for DNP nurses in a consultative role is to remain aware of
politics, policy making, and of the importance of forming partnerships when planning a systems
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change. Depending on one’s practice location communications may need to involve additional
key stakeholders as partners in the planning to ensure that implementation proceeds effortlessly
and efficiently. For example, providing a proposal to labor representatives for review and
comment prior to overall group planning sessions may alleviate unnecessary future controversy.
Labor representatives can provide another voice for frontline staff during future discussions
involving the proposed change, and members may be inclined to speak more directly about
concerns with their representative.
Potential transferability of project findings. The findings from the project itself are
transferable to some extent. Three initial issues should be considered. First it is important to
consider this as a pilot project because the anticipated number of cases was not observed,
resulting in a limited number of cases. Second, the facility interested in a similar study should
know the prevalence of MRSA in the institution prior to beginning an investigation. This would
assist the researcher to a more accurate estimate of the number of expected cases and in
determining the number of historical controls to choose. Third, this was a convenience sample,
not a randomized one. Randomization may create difficulty obtaining sufficient numbers of
cases and controls depending on the criteria identified for matching. This would also increase
the length of time that the study would be implemented.
Assuming further interest in a similar project, the first requirement would be that the
facility had the capability to perform PCR analysis of the nares swabs. Without the forty-five
minute to one hour turnaround time PCR analysis offers it would not be possible to begin
decolonization at the time of the surgical procedure. Cultures require twenty-four to forty-eight
hours for results of swabs collected from patients arriving on the day of surgery. A similar
project would not be possible in a facility without MRSA PCR analysis capabilities.
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If a facility has the ability to perform PCR analysis of the nares swabs it would be
prudent to align with other sites to implement a multisite project in order to increase the sample
size overall which would improve the likelihood of identifying more cases. This would
contribute to the generalizability of the study results. Greater numbers would also permit a
regression analysis and would result in odds ratios that could be examined. Finally, the timeline
for the study should be extended to greater than the one year implemented for this pilot project.
This would assist in determining an association between decolonization and a decrease in SSI
rates.
The skills required by the nurse investigator for this project are transferable to other
system change projects. Knowledge of evidence-based practice, nursing and change theory,
organizational culture, negotiation skills, and multidisciplinary collaboration all have farreaching application.
Dissemination plan. The initial dissemination of the project results will be in a public
presentation at the university where the investigator is enrolled in the DNP program. There are
numerous other potential options for disseminating the results. One is to present the findings at
the project site’s nursing grand rounds. This will be in addition to presenting at staff meetings
for the operating room nurses, CRNAs, microbiology lab, pharmacy, and to nurses on the
surgical unit. The results will also be presented at the operating room committee and at the
onsite orthopedic surgery subspecialty meeting. In addition, there are two poster presentation
opportunities in the site facility. One is during research week and the other during nurse’s week.
The onsite nurse newsletter has requested an article about the project.
Externally, a submission for a poster presentation to peers in infection prevention and
control at the annual state APIC conference will be completed. A regional group of nurses who
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collect surgical quality improvement data have requested a web-conference presentation. It is
possible to present to a similar regional group of infection preventionists. Finally, the possibility
exists to submit an article to a nursing journal.
The project as a foundation for future scholarship. This project provides a foundation
for future nursing scholarship. It may directly impact scholarship relative to MRSA
decolonization if the investigator expands the pilot project. Indirectly, the project affects
scholarship because the skills demonstrated by the nurse investigator are generic to any project
where evidence-based practice is applied to improve quality health outcomes, and the results of
the applied research are disseminated to address issues in clinical practice. Doctoral prepared
nurses are willing and ready to examine and revise existing nursing practice to produce improved
outcomes and patient satisfaction. They are nurse leaders who have designed and implemented a
project beginning with developing the research question to disseminating the practice innovation.
Confidence is gained or increased by completing such a project. This is empowering, which is
valuable because it can be challenging to change clinical practice.
American colleges of nursing essentials. A DNP project must be scholarly. It should
be developed with the intent of translating research findings into practice. This project
implemented a change in the standard of care in the clinical setting of total hip and total knee
joint replacement surgery as a strategy to temporarily decolonize patients beginning on the day
of surgery, and potentially prevent SSIs in this patient population.
The project was in keeping with the American Association of Colleges of Nursing
(AACN) Essentials of Doctoral Education for Advanced Nursing Practice (2006). Related to
Essential I, Scientific Underpinnings for Practice, the nurse investigator formed a
multidisciplinary group to plan and implement the project that included: pharmacy, the
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orthopedic nurse coordinator, CRNAs, the clinical microbiology laboratory, two nurse managers,
the chief of orthopedic surgery, and the hospital epidemiologist. Concepts and principles from
all disciplines were discussed and integrated into the protocol. The group determined
decolonization to be a significant strategy to enhance health care delivery. Implementing
decolonization was a new practice approach for the facility.
Essential II, Organizational and Systems Leadership for Quality Improvement and
Systems Thinking (2006), was also addressed by the project. Business principles were applied in
discussion with pharmacy and informatics staff. The investigator negotiated with pharmacy
concerning the use of a small unit dose tube of ointment by the CRNAs in the operating room,
and the use of a multi-dose tube of ointment for use on the surgical unit and for patient use
during the two days following discharge. When considering cost benefit, the use of unit dose
tubes were more efficient and less wasteful for the CRNAs in the operating room who were
administering the initial dose of ointment. When this was determined informatics staff became
involved to build the pre and postoperative order sets.
The above is an example of a small portion of this pilot project, which following
implementation offered support for the hypothesis that beginning decolonization on the day of
surgery in a supportive environment can result in temporary decolonization. This may improve
post-operative health outcomes, and avoid the expenses that may be incurred with an extended
hospitalization associated with a SSI.
The project was also in keeping with Essential III, Clinical Scholarship and Analytical
Methods for Evidence-Based Practice (2006). Gaps in practice were identified with review of
the first patients who participated in the decolonization protocol. The outcomes were evaluated
at the facility locally, but indirectly had implications for practice at the regional level as the
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facility was and is a referral site for THA and TKA surgeries. Practice guidelines were
formalized again and resident staff re-educated. The protocol was then included in the handbook
provided to all residents in the Orthopedic Surgery Subspecialty.
Essential IV, Information Systems/Technology and Patient Care Technology for the
Improvement of Health Care (2006), was addressed as well during the project. Order sets for the
protocol were developed by the nurse investigator and a clinical applications coordinator. Data
was abstracted from the electronic medical record and entered into a spreadsheet for analysis.
Knowledge gained from continuous review of the overall process was summarized and added to
the protocol entered into the handbook described above.
Implementing the project further developed knowledge and skills for the nurse
investigator related to Essential V, Health Care Policy for Advocacy in Health Care (2006). An
issue, no existing standard of care for decolonization of patients undergoing THA or TKA
surgery, was identified and action was taken to change practice. The process required a multidisciplinary approach and consensus building. As stated earlier, the protocol is unique to the
facility where the project was implemented, but influences a regional patient population through
referrals made by other facilities for THA and TKA surgery.
Essential VI, Inter-professional Collaboration for Improving Patient and Population
Health Outcomes (2006), suggests that the DNP use communication and collaboration skills to
develop and implement practice guidelines. The nurse investigator was the leader in planning
and implementing the pilot project. Partners from other disciplines were invaluable in
developing a project that offers support for a decolonization protocol beginning on the day of
surgery.

MRSA DECOLONIZATION

47

The decolonization pilot project met Essential VII, Clinical Prevention and Population
Health for Improving the Nation’s Health (2006). Project findings suggest that this is a clinical
prevention strategy that may result in temporary decolonization in the perioperative period,
which may contribute to decreased morbidity by reducing the number of SSIs. Patients receiving
total hip or total knee implants were the population served. Healthy People 2010 included
Developmental Objective 2-6: Eliminate racial disparities in the rate of total knee replacements.
This project did not directly address racial disparities and joint replacement, but was in keeping
with a history of studying orthopedic implants related to a population-based health outcome.
Finally, regarding Essential VIII, Advanced Nursing Practice (2006), the nurse
investigator leading the project met these components as the project evolved. The nurse
designed, implemented and evaluated the decolonization pilot. Although therapeutic
relationships were not established with the patient population, professional relationships with
other disciplines were enhanced by developing a new intervention and changing practice. This
project demonstrates leadership and independence in nursing practice, in advancing
interdisciplinary partnerships, and in influencing patient health outcomes through a systems
change.
Closing. This project has implications for DNPs and other health professionals who are
involved in providing care during the perioperative period for patients undergoing THA and
TKA surgery. Methicillin-Resistant Staphylococcus aureus prevalence will vary by facility, and
thus the risk of colonization, transmission, and potential for SSI. Continued attention must be
directed toward developing evidence-based protocols that will reduce the above risks and result
in quality health care outcomes along with patient satisfaction. Adherence to protocol as in the
case of this project will rely not only on the health professionals, but also on the patients. This
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pilot project suggests that identifying existing nasal MRSA and beginning decolonization on the
day of surgery for patients undergoing THA or TKA surgery may effectively result in temporary
decolonization during the perioperative period and may potentially prevent a MRSA SSI.
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Appendix A: Nola J. Pender (1996) Health Promotion Model Diagram, www.http://hdl.handle.net/2027.42/85351 [used with permission]
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Study
(Author,
Year)
Kim, D.
et al,
2010

58
TABLE OF STUDY CHARACTERISTICS – Quantitative (Table 1)

Purpose

Population/
Sample

Research
Design

Intervention

Comparison

Evaluate
MRSA
screening and
eradication in
elective
Orthopedic
surgery
patients

7019/7338
convenience
sample

Prospective
cohort
(7/20069/2007) with
historic control
period
(10/20057/2006)

Mupriocin
ointment bid
x 5 days and
CHG shower
daily x 5days
if MRSA
positive nares
screen

4238/5200
convenience
sample in
VA hospital
with routine
admission
nasal swabs

Retrospective
cohort with
nares
screening
within 31 days
of clean or
clean
contaminated
surgery from
10/1/20089/30/2009

None

Primary: rates
of SSI during
study period
and control
period
Secondary:
rates of SSI
between
MRSA/MSSA
carriers and
non-carriers
during the
study period
Post-op
outcomes in
MRSA
positive and
MRSA
negative
patients and
the impact of
pre-op
vancomycin

Gupta, K. Determine if
et al,
MRSA nares
2011
carriage is
predictor of
SSI

Outcome
Measures/
Scales
Carrier status
Rates of SSI

Associations
between
positive pre-op
MRSA swab
and poor postop outcomes

Results

SSI rate during study
period lower than in
control period (59%
reduction rate,
p=0.009), Higher SSI
rate in MRSA carriers
compared with noncarriers (p=0.016)
during study period

Positive pre-op MRSA
culture significant for
positive post-op culture
(p<0.001), MRSA SSI
(p=0.01), and other
post-op infection
(p<0.01) unadjusted.
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(Author,
Year)
Yano, K.
et al,
2009

Hadley,
S. et al,
2010
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Purpose

Population/
Sample

Research
Design

Intervention

Comparison

Examine the
relationship
between preop nares
MRSA
colonization
and post-op
SSI

Convenience
sample of
63/2432 with
positive
MRSA nares
screens who
had
orthopedic
surgery

Prospective
cohort from
4/1/20036/30/2005

None

Relationship
of positive
nares pre-op
and
subsequent
SSI

Compare the
rates of SSIs
in THA and
TKA patients
completing an
MRSA
decolonizetion protocol
to patients not
following the
protocol

1644/2058
(treatment
group)
adhered to
routine
decolonizetion protocol
(selected by
attending
admit nares
screening
clinic), 414
non-adherent
(control
group) did
not attend
clinic

Prospective
cohort from
11/20076/2009

Patients
screened for
MRSA given
mupirocin
ointment x 5
days and
CHG shower
x1. If nares +
on day of
surgery
Vancomycin
as pre-op
antibiotic

Compare SSI
rates in
patients
adhering to
protocol with
non-adherent

Outcome
Measures/
Scales
OR for MRSA
SSI with preop positive
nares

Descriptive
statistics for
SSI rate
between
protocol
adherent and
non-adherent

Results

+ nares and develop
MRSA SSI crude OR=
15 (4.5-47), p<0.001;
+ nares and develop
MRSA SSI adjusted
OR= 11 (3.0-37),
p<0.001; negative
nares and develop
MRSA SSI crude and
adjusted OR =1
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Study
(Author,
Year)

Purpose

Population/
Sample

Research
Design

Intervention

Price, C.
et al.,
2008

Determine the
prevalence of
pre-op S.
aureus nasal
colonization
in Orthopedic
patients,
assess trends
in methicillin
resistance
with time,
ascertain risk
factors for
nasal
colonization,
and to
correlate SSI
to nasal
colonization
status and
procedure

284 patient
nares swabs
collected,
patients
screened x 1
2 weeks prior
to scheduled
surgery

Cross sectional None
sample
9/19/20039/26/2005

Comparison

Outcome
Measures/
Scales

Results

None with
primary
objective (%
colonized), 2°
objective:
correlate SSI
to
colonization
status and
procedure

Percent
colonized,
correlation
between
carriage, SSI
or surgical
procedure

86/284 colonized, 81
with methicillin
sensitive S. aureus and
5 with MRSA, number
of MRSA carriers did
not increase from 20032005; no correlation
between MRSA
carriage, demographic
data, SSI, or surgical
procedure
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Study
(Author,
Year)

Purpose

Population/
Sample

Research
Design

Intervention

Comparison

Buelhmann
M. et al.,
2008

Evaluate
efficacy of
decolonization
and identify
factors
influencing
failure

62/94
convenience
sample of
consecutive
hospitalized
patients

Prospective
cohort from
1/1/20024/30/2007

Mupirocin
BID x 5
days,
Oral rinsing
with 2%
CHG TID,
4% CHG
daily body
wash,
antimicrobial
(oral) once or
twice daily
for urogenital
or
gastrointestinal
colonization

Percent
colonized on
admit, percent
colonized
after
decolonizatio
n cycle

Outcome
Measures/
Scales
Percent
decolonized
after
completing full
decolonization
cycle

Results

Decolonization
completed in 87%
(54/62) with a mean of
2.1, SD + 1.8. MRSA
sites: nose 68%
(42/62), throat 53%
33/62, perianal 53%
33/62, rectal 58%
(36/62), inguinal 49%
(30/62). 65% required
oral antibiotic
treatment to decolonize
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Study
(Author,
Year)

Purpose

Lee, A. et Determine
al, 2011
whether
resistance to
mupirocin and
CHG increases
the risk of
persistent
MRSA
carriage after
decolonization

62
Population/
Sample

Research
Design

Intervention

Comparison

Outcome
Measures/
Scales

Results

Hospitalized
patients: 75
case patients
and 75
controls

Case control

None

Characteristics of cases
and controls

Identify factors
associated with
failure to
decolonize

Independent risk
factors associated with
decolonization failure
(adjusted ORs):
combined mupirocin
and CHG resistance
OR=3.4, 95% CI (1.57.8), p=0.004; age/1yr
increment OR=1.04,
95% CI (1.02-1.1),
p=0.001; hospital
within 2 yrs OR=2.4,
95% CI (1.1-5.7),
p=0.04; wound/ulcer
OR=5.7, 95%CI (1.817.6), p=0.003; MRSA
inactive antibiotic use
OR=3.1, 95% CI (1.37.2), p=0.01; central
line OR=5.7, 95% CI
(1.4-23.9), p=0.02
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Appendix C: Table Ranking the Evidence for Clinical Practice Guidelines and Systematic Reviews (Table 2)
Study Author

Purpose

Population

Results

APIC, 2010

Eliminate
MRSA in
hospital setting

Patients and
providers in
hospital setting

APIC, 2010

Eliminate
orthopedic SSIs

Patients,
surgeons,
perioperative
personnel

Strategies:
surveillance, hand
hygiene, contact
precautions,
environmental
hygiene,
education, cultural
transformation,
antimicrobial
stewardship,
decolonization
Strategies to
prevent
orthopedic SSIs
related to
modifiable and
non-modifiable
risk factors

Liu, 2011

Treatment of
MRSA
infections

Patients (adults
& children) and
providers

Recommendations
for management
of MRSA clinical
syndromes
associated with
MRSA

Practice
Applicability
Clinical setting
& patients
similar to those
in guideline

Risk/Benefit

Level/Quality

Benefit:
temporary
decolonization
during
perioperative
period; Risk:
possible
mupirocin
resistance

Level 5
(observational,
some casecontrol/cohort
studies & many
opinion/committee
reports) Good

Clinical setting
& patients
similar to
guideline

Benefit:
decreased SSI
rate; Risk: may
decrease other
hospitalacquired
infection but not
necessarily SSI
Benefit:
Standardized
treatment
protocol; Risk:
consideration of
patient values &
preferences,
possible
resistance issues

Level 5
(observational,
some casecontol/cohort
studies & many
opinion/committee
reports) Good

Clinical setting
& adult patients
similar to
guideline

Level 3 (clinical
practice guideline,
evidence from
well-designed
RCTs, is an
opinion of
authorities on an
expert panel)
Good
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McGinigle,
2008

Use of active
Patients in
surveillance
MICU or SICU
cultures (ASC)
to reduce MRSA

Existing evidence
favors use of
ASCs, as
evidence is poor
recommendations
can’t be made

ASC required
by VA Directive
in clinical
setting

van Reijen,
2011

Determine if
nasal mupirocin
in patients with
MRSA/MSSA
reduces S.aureus
infection rates

Use of mupirocin
in nasal S. aureus
carriers is
associated with a
decrease in S.
aureus infections

Clinical setting
similar to those
in guideline

Surgical &
dialysis patients,
non-surgical
MRSA nares
colonized
patients

Benefit: control
increasing
numbers of
infections; Risk:
< staff contact
with isolation, >
financial cost
with isolation
Benefit:
reduction in rate
of hospitalacquired
infections;
Risk: possible
mupirocin
resistance

Level 5
(systematic
review) Review
itself was good
although negative
as studies of poor
quality. Good
Level 1
(systematic
review) Based on
9 RCTs. Four
were considered
high quality.
Good
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APPENDIX D: AGREE II Online Appraisal Tool
A critical appraisal of:
Clinical Practice Guidelines by the Infectious Diseases Society of America for the
Treatment of Methicillin-Resistant Staphylococcus Aureus Infections in Adults and
Children
using the AGREE II Instrument
Created with the AGREE II Online Guideline Appraisal Tool.
No endorsement of the content of this document by the AGREE Research Trust should be
implied.
Appraiser: Laurel Chelstrom
Date: 12 May 2012
Email: ljchelstrom@stkate.edu
URL of this appraisal: http://www.agreetrust.org/view-appraisal/?doc=2294

Overall Assessment
Title: Clinical Practice Guidelines by the Infectious Diseases Society of America for the
Treatment of Methicillin-Resistant Staphylococcus Aureus Infections in Adults and Children
Citation:
Overall quality of this guideline: 6/7
Guideline recommended for use? Yes

MRSA DECOLONIZATION
Notes
Guideline sections begin with a question followed by quantified recommendations with a
summary of recent evidence supporting the recommendation. There is a research gaps section
which discusses areas of limited/conflicting data or the need for additional research.
Domain
Total
1 - Scope and Purpose
21
2 - Stakeholder Involvement 11
3 - Rigour of Development 46
4 - Clarity of Presentation 21
5 - Applicability
19
6 - Editorial Independence 14
1. Scope and Purpose
1. The overall objective(s) of the guideline is (are) specifically described.
Rating: 7 Strongly Agree
Yes, in the brief executive summary.
2. The health question(s) covered by the guideline is (are) specifically described.
Rating: 7 Strongly Agree
Yes, expressed in question form and specific responses for adult or pediatric patients.
3. The population (patients, public, etc.) to whom the guideline is meant to apply is
specifically described.
Rating: 7 Strongly Agree
Yes, adults and children with MRSA infections.

2. Stakeholder Involvement
4. The guideline development group includes individuals from all relevant professional
groups.
Rating: 2
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Reviewer was unable to determine. Organizations are specified for the individuals, not their titles
or roles. All authors/panelists are considered infectious disease experts in management of
MRSA.
5. The views and preferences of the target population (patients, public, etc.) have been
sought.
Rating: 2
External peer review feedback of the draft is reported in the document. No report of comments
from patients or the public concerning the development of the document.
6. The target users of the guideline are clearly defined.
Rating: 7 Strongly Agree
Yes, practitioners and patients.

3. Rigour of Development
7. Systematic methods were used to search for evidence.
Rating: 3
The search identified PubMed as the database. A limit was English-language only. Years
searched were from 1961-2010. Search terms used were “methicillin-resistant Staphylococcus
aureus” or “MRSA.” The focus was on human studies however some experimental animal
studies, in vitro data, and abstracts from national meetings were included. The authors reported
many recommendations were developed from observational studies or small case series studies
combined with the opinion of expert panel members.
8. The criteria for selecting the evidence are clearly described.
Rating: 7 Strongly Agree
Yes, an A (good evidence to support a recommendation for or against use), B Moderate evidence
to support a recommendation for or against use), C (Poor evidence to support a recommendation)
scale was used to rate the strength of recommendations.
A scale for quality of evidence was scored as: I (evidence from ≥ 1 properly randomized
controlled trial); II (evidence from ≥ 1 well designed clinical trial, without randomization from
cohort or case-controlled analytic studies, preferably from > 1center; from multiple time-series,
or from dramatic results from uncontrolled experiments); and III (evidence from opinions of
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respected authorities based on clinical experience, descriptive studies or reports of expert
committees).
9. The strengths and limitations of the body of evidence are clearly described.
Rating: 7 Strongly Agree
Yes, detailed narrative descriptions are included for each question.
10. The methods for formulating the recommendations are clearly described.
Rating: 7 Strongly Agree
Yes, use of teleconference and annual meetings of all members. All members participated in
preparation and review of the draft guideline. Feedback from external peer reviewers was
obtained. Guideline was endorsed by Pediatric Infectious Diseases Society, American College of
Emergency Physicians, and American Academy of Pediatrics. The guideline was reviewed and
approved by IDSA Standards and Practice Guidelines Committee and the IDSA Board of
Directors.
11. The health benefits, side effects, and risks have been considered in formulating the
recommendations.
Rating: 7 Strongly Agree
Discussions and recommendations are detailed and decisions are clear and succinct.
12. There is an explicit link between the recommendations and the supporting evidence.
Rating: 7 Strongly Agree
Yes, evidence-based literature is referenced throughout the document.
13. The guideline has been externally reviewed by experts prior to its publication.
Rating: 7 Strongly Agree
Yes, reviewer commented on this earlier in #10 under Rigour of Development.
14. A procedure for updating the guideline is provided.
Rating: 1 Strongly Disagree
Reviewer did not see a procedure in place for this.
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4. Clarity of Presentation
15. The recommendations are specific and unambiguous.
Rating: 7 Strongly Agree
The recommendations are clearly detailed and followed with an evidence summary.
16. The different options for management of the condition or health issue are clearly
presented.
Rating: 7 Strongly Agree
Yes, alternatives are presented (see decolonization for example) and are stratified by adult and
child.
17. Key recommendations are easily identifiable.
Rating: 7 Strongly Agree
Yes, some key recommendations are identified in the executive summary and some are identified
as performance measures on the concluding page of the document.

5. Applicability
18. The guideline describes facilitators and barriers to its application.
Rating: 4
Not clearly labeled as facilitators or barriers, or stated in a particular section. Caution and
controversy are noted appropriately.
19. The guideline provides advice and/or tools on how the recommendations can be put into
practice.
Rating: 7 Strongly Agree
Yes, throughout the document.
20. The potential resource implications of applying the recommendations have been
considered.
Rating: 7 Strongly Agree

MRSA DECOLONIZATION

70

Yes, for example personal and environmental hygiene and wound care in the home are discussed.
21. The guideline presents monitoring and/or auditing criteria.
Rating: 1 Strongly Disagree
Implied in some areas but not defined.

6. Editorial Independence
22. The views of the funding body have not influenced the content of the guideline.
Rating: 7 Strongly Agree
All panel members complied with IDSA policy including actual, potential or apparent conflict of
interest. Panel members were asked to identify links to companies developing products that may
be influenced by dissemination of the guideline. Information was requested regarding
employment, consulting, stock ownership, honoraria, research funding, expert testimony, or
participation on company advisory committees.
23. Competing interests of guideline development group members have been recorded and
addressed.
Rating: 7 Strongly Agree
Potential conflicts of interest were listed in the Acknowledgement section.

Created online at www.agreetrust.org12 May 2012
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Appendix E: Table Ranking the Evidence for Systematic Reviews (Table 3)
Study Author

Purpose

Population

Results

McGinigle, 2008 Use of active
surveillance
cultures (ASC)
to reduce MRSA

Patients in
MICU or SICU

Existing
evidence favors
use of ASCs, as
evidence is poor
recommendations
can’t be made

van Reijen, 2011

Surgical &
dialysis patients,
non-surgical
MRSA nares
colonized
patients

Use of mupirocin Clinical setting
in nasal S. aureus similar to those
carriers is
in guideline
associated with a
decrease in S.
aureus infections

Determine if
nasal mupirocin
in patients with
MRSA/MSSA
reduces S.aureus
infection rates

Practice
Applicability
ASC required by
VA Directive in
clinical setting

Risk/Benefit

Level/Quality

Benefit: control
increasing
numbers of
infections; Risk:
< staff contact
with isolation, >
financial cost
with isolation
Benefit:
reduction in rate
of hospitalacquired
infections;
Risk: possible
mupirocin
resistance

Level 5
(systematic
review) Review
itself was good
although
negative as
studies of poor
quality.
Level 1
(systematic
review) Good
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Appendix F: Ranking the Evidence (Table 4)
Literature

Level Ranking

Quality Ranking

APIC, 2010 (MRSA guideline)
APIC, 2010 (Orthopedic guideline)
Liu, C, et al, 2011 (IDSA guideline)
McGinigle, K, 2008 (systematic review)
van Rijen, M, 2011 (systematic review)
Gupta, K. et al, 2011 (original article)
Kim, D. et al, 2010 (original article)
Yano, K. et al, 2009 (original article)

Level 5
Level 5
Level 3
Level 5
Level 1
Level 4 (retrospective cohort)
Level 4 (prospective cohort)
Level 4 (prospective cohort)

Good
Good
Good
Poor
Good
Good
Good
Good

Rating System for the Hierarchy of Evidence for Intervention/Treatment Questions:
Level 1: Systematic review or meta-analysis of all relevant randomized controlled trials (RCTs), or evidence-based clinical practice
guidelines based on systematic reviews of RCTs
Level 2: Evidence from at least one well-designed RCT
Level 3: Evidence from a well-designed controlled trial without randomization
Level 4: Evidence from well-designed case-control and cohort studies
Level 5: Evidence from systematic reviews of descriptive and qualitative studies
Level 6: Evidence from a single descriptive or qualitative study
Level 7: Evidence from the opinion of authorities and/or reports of expert committees
(Melnyk, & Fineout-Overholt, 2011, p. 12). Modified from Guyatt, G., & Rennie, D. (2002). Users’ guides to the medical literature.
Chicago, IL: American Medical Association; Harris, R. P., Hefland, M., Woolf, S. H., Lohr, K. N., Mulrow, C. D.,
Teutsch, S. M., et al. (2001). Current methods of the U. S. Preventive Services Task Force: A review of the process.
American Journal of Preventive Medicine, 20, 21-35.

Quality Criteria:
Good: Evidence includes consistent results from well-designed, well-conducted studies in populations that directly assess effects on
health outcomes. (Quality Criteria continue on the next page)
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Fair:

Evidence is sufficient to determine the effects on health outcomes, but the strength of the evidence is limited by the number,
quality, or consistency of the individual studies, generalizability to routine practice, or indirect nature of the evidence on
health outcomes.

Poor:

Evidence is insufficient to assess the effects on health outcomes because of limited number or power of studies, important
flaws in their design or conduct, gaps in the chain of evidence, or lack of information on important health outcomes.

U. S. Preventive Services Task Force (USPSTF) [May 2008] grades the quality of the overall evidence for a service on a 3-point
scale (good, fair, poor).
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Appendix G: Flowchart: Collection of Nasal Swab for MRSA Surveillance
Go to clean storage
room

Get culturette and
biohazard bag

Go to desk

Go to cart

Perform hand
hygiene

Complete lab slip
and label

Get lab request slip
and label

Get gown and
disposable gloves

Don gown and gloves

Verify patient
(check armband)
fo forID

Explain procedure to
patient

Get MRSA nares swab
order from CPRS

Same swab, repeat other
nostril

Yes
Insert swab 1” into
nostril, roll x3

Open package,
remove swab

Y/N to
nares swab

No
Return swab to tube
Swab collection ended,
document in CPRS

Label tube, place in
biohazard bag

Remove gown and
gloves

Gown to hamper
Gloves to trash

Perform hand hygiene

Send tube and request
to lab
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Appendix H: Anesthesia workflow diagram for decolonization of MRSA positive THA and TKA patients
MRSA
swab
collected
on 2L/2K

Micro lab
analyzes the
specimen

Lab only
calls
positive
results to
Anesthesia

Anesthesia
calls new
positive into
OR

0745 case
MTThF & 0845
case W: Y/N

Yes
Mupirocin
only

Yes
No

Cefazolin
given: Y/N
No

• Known MRSA positive patients are
flagged in CPRS postings.
• Check with Orthopedics about
orders for vancomycin and
mupirocin for newly MRSA
positive patients
• Orthopedics is responsible for
writing orders for known MRSA
positive patients

Vancomycin
and
mupirocin

Instructions for opening and applying
Bactroban nasal (Mupirocin calcium
ointment 2%) from the 1 X 1.0 gram
single-use tube are found on the back of
the package.

No

Vancomycin
and
Mupirocin
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Appendix I: Table 5, Cost Spreadsheet Based on 30 THA and TKA Surgeries/Month
(Costs highlighted in yellow are annual repeating costs based on a 10% facility prevalence of
MRSA, assuming 3 THA or TKA patients/month will be either newly or known MRSA positive)
Supplies/other
variable
1 THA/TKA SSI
2 Admit PCR assay
3 Discharge Agar
plate
4 Vancomycin x 24
hours
5 Ancef x 24 hours
6 Mupirocin unit
dose
7 Mupirocin
multidose
8 Staff education by
IP*
8a 2nd floor RNs**
by IP

8b CRNAs*** by IP

8c Lab staff† by IP

8d Pharmacy†† by
IP
9 Mtgs w/Ortho
Chief & IP†††

10 Mtgs w/Ortho RN
& IP
(Administration)
11 Computer
template, CAC• & IP
12 SubTotals
(Yellow):
13 Totals:

New Cost

Avoided Cost

Averted Cost
‡$50,000.00

$51.00(3)(12)=$1836.00
$14.00(3)(12)=$504.00

$7.00(3)(12)=$252.00
$3.00(3)(12)=$108.00
$5.00(3)(12)=$180.00
$5.00(3)(12)=$180.00

$100.00 (4x30”) IP
RN
$800.00 (rounds x 4)
for 8 nurses
$25.00 (1x30”) IP RN
$800.00 (staff mtg x1)
for 32 CRNAs
$13.00 (1x15”) IP RN
$200.00 (staff mtg x1)
for 12 lab personnel
$50.00 (1x60”) IP RN
$50.00 (1x60”)
PharmC
$150.00 (3x60”) IP
RN
$375.00 (3x60”)
OrthC
$250.00 (5x60”) IP
RN
$250.00 (5x60”)
OrthRN
$150.00 (3x60”) CAC

$720.00
$3933.00

$2340.00
$2340.00

$50,000.00
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All salaries below are hypothetical. All amounts above were rounded for ease of calculation.
Drug costs were estimated by Pharmacy. Pharmacy tech time is included, thus true drug cost to
VA may vary from above amounts if actual tech grade and step data is considered.
*Infection Prevention RN salary=$50.00/hour
**2nd floor RN salary=$50.00/hour
***CRNA salary=$50.00/hour Orthopedics Chief salary=$125.00/hour
†Lab personnel salary=$16.00/hour
††Pharmacy assistant chief salary=$50.00/hour
†††Chief of Orthopedics salary=$125.00/hour
•Computer applications coordinator (CAC) salary=$50.00/hour
‡2003 article quoted cost of a THA/TKA SSI as approximately $50,000.00. This amount
appears more often in the literature than the $100,000.00 amount quoted in the 2012 article.
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Appendix J: Lab Costs for MRSA Nasal Swab Surveillance

PCR assay costs (admission*):
Tech accessioning time=2 minutes=$3.60
PCR consumables=$35.14
Setup time=3 minutes=$5.40
Tech time to read and report out=2 minutes=$3.60
Materials needed to process:
1 ten part label=$0.01
2 staples=$0.01
1 card stock (workcard)=$0.02
1 pair nitrile gloves per specimen=$1.75
1 COPAN swab=$0.80
Bleach and alcohol to countertop after setup per specimen=$0.10
Total=$50.43 per PCR specimen

Agar plating costs (discharge):
Tech accessioning time=2 minutes=$3.60
Agar plate cost=$2.33
Plating time=1 minute=$1.80
Tech time to read and report out=2 minutes=$3.60
Materials needed to process:
1 ten part label=$0.01 2 staples=$0.01
1 card stock (workcard)=$0.02
1 pair nitrile gloves per specimen=$1.75
1 COPAN swab=$0.80
Total=$13.92 per agar specimen

*Admission lab is more costly to process as results are available in 45 minutes to 1 hour, so
patients can be placed in isolation precautions more quickly. The discharge swab is plated and
less expensive because results are not available for 24-48 hours. Isolation precautions are no
longer critical once the patient is discharged.
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Appendix K: Cost Benefit Summary Calculations
Total decolonization costs for initial year: $3933.00
Total averted cost if one THA/TKA SSI is averted: $50,000.00
Total avoided annual cost for admission and discharge labs: $2340.00
Total benefits: $52,340.00

Benefit Cost Ratio = Total benefits/Total costs = $52,340/$3933 = 13.3

Return on investment (ROI) = Total benefits – Total costs/Total costs x 100 =
($52,340 - $3933)/$3933 x 100 =
($48,407/$3933) x 100 = 1230 = ROI
ROI figure is greater than zero it is worthwhile to consider investing in this project. A limitation
is possible development of Mupirocin resistance. Decolonization should be limited to high risk
and high volume surgical procedures such as those with permanent implants like THAs and
TKAs.
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Appendix L: Present Value Calculation

Assume medical cost avoided for 1 THA/TKA SSI = $50,000
Assume 5% interest

Present Value of 5 years avoided medical cost of 1 SSI assuming a 5% interest rate:
PV savings in year 1:
PV savings in year 2:
PV savings in year 3:
PV savings in year 4:
PV savings in year 5:

$50,000/$1.05=$47,619.05
$50,000/(1.05)²=$45,351.47
$50,000/(1.05)³=$43,191.88
$50,000/(1.05)4=$41,135.12
$50,000/(1.05)5=$39,176.31

$47,619.05+$45,351.47+$43,191.88+41,135.47+$39,176.31=$216,473.83
Total: $216,473.83 = Savings in present value terms
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Appendix M: Table 6
Descriptive statistics
Variable

Statistic

Gender
Female
Male

Percentage (Number)

Age
Cases
Controls

Mean (Std. Dev.)

BMI
Cases
Controls

Mean (Std. Dev.)

Subjects
0% (0)
100% (50)

62.90 yrs. (6.226 yrs.)
62.90 yrs. (5.991 yrs.)

33.19 lbs. (6.006 lbs.)
31.67 lbs. (6.349 lbs.)
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Appendix N: Table 7
Variables in the Project
MRSA positive on admission
MRSA positive history
MRSA positive on discharge
Gender
ASA score
Length of preoperative stay
Type of surgery
Location of surgery
Duration of surgery
Wound class
Preoperative antibiotic
Mupriocin administered
Postoperative antibiotic
Diabetic chronic
Tobacco use
Albumin level within 90 days
Acute renal failure
Current dialysis
Chronic obstructive pulmonary disease
Tranexamic acid administered
SSI within 30 days
SSI within 90 days
Postoperative day of infection
Depth of SSI
Site cultured
Pathogen
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Appendix O: Table 8
Case and Control Result Summary
Variable

Cases

Controls

Overall

Χ²

p value

MRSA admit +

100% (10)

2.5% (1)

22% (11)

44.318

.000

MRSA hx +

50% (5)

2.5% (1)

12% (6)

17.093

.001

MRSA d/c +

30% (3)

2.5% (1)

8% (4)

8.220

.022

ASA score
1
2
3
4

0% (0)
0% (0)
100% (10)
0% (0)

2.5% (1)
27.5% (11)
67.5% (27)
2.5% (1)

2.0% (1)
22% (11)
74.0% (37)
2.0% (1)

4.392

.222

Pre-op stay

100% (10)

100% (40)

100% (50)

Surgery type
THA
TKA

50% (5)
50% (5)

50% (20)
50% (20)

50% (25)
50% (25)

.000

.637

Surgery side
Right
Left

70% (7)
30% (3)

70% (28)
30% (12)

70% (35)
30% (15)

.000

.659

Surgery length
1 to<2hrs
2 to>2hrs

30% (3)
70% (7)

42.5% (17)
57.5% (23)

40% (20)
60% (30)

.521

.365

Wound class

100% (10)

100% (40)

100% (50)

Preop abx
Cefazolin
Vancomycin
Clindamycin

30% (3)
70% (7)
0% (0)

85% (34)
0% (0)
15% (6)

74% (37)
14% (7)
12% (6)

32.770

.000

Mupirocin

70% (7)

0% (0)

14% (7)

32.558

.000

Postop abx
Cefazolin
Vancomycin
Clindamycin

30% (3)
70% (7)
0% (0)

82.5% (33)
5% (2)
10% (4)

72% (36)
18% (9)
8% (4)

23.090

.000
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DM chronic
No
Diet
Oral
Insulin

20% (2)
20% (2)
40% (4)
20% (2)

80% (32)
2.5% (1)
7.5% (3)
10% (4)

68% (34)
6.0% (3)
14% (7)
12% (6)

15.021

Tobacco use
Never
w/in 2 weeks
w/out > 12 mo.

10% (1)
20% (2)
70% (7)

0% (0)
22.5% (9)
77.5% (31)

2% (1)
2% (11)
76% (38)

4.082

.130

Albumin w/in 90d

100% (10)

90% (36)

92% (46)

1.087

.397

Acute renal failure

100% (10)

100% (40)

100% (50)

Current dialysis

100% (10)

100% (40)

100% (50)

COPD

10% (1)

10% (4)

10% (5)

.000

.742

Tranexamic acid

40% (4)

0% (0)

8% (4)

17.391

.001

SSI<30d

0% (0)

2.5% (1)

2% (1)

.255

.800

SSI 30-90d

0% (0)

2.5% (1)

2.0% (1)

.255

.800

POD of SSI
<30d
30-90d

0
0

pod 10
pod 82

Depth of SSI
Superficial
0
Deep
0
Organ/space (joint) 0

0
0
2

Site cultured
Right
Left

0
0

2
0

Pathogen

none

CNS (1)
Group B beta streptococcus (1)

a. Cell count <5, computed for 2x2 table only.
b. No statistics are computed, variable is a constant.

.002

